data_2lqp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.649 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 144' ' ' MET . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.549 ' H ' ' C ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.659 ' HE ' ' HH ' ' A' ' 138' ' ' TYR . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.659 ' HH ' ' HE ' ' A' ' 90' ' ' ARG . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.952 0.406 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.548 ' ND2' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.502 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.567 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.936 0.398 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 96' ' ' GLY . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' ND2' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.445 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.805 HD22 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.563 ' N ' HD21 ' A' ' 137' ' ' ASN . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.805 ' H ' HD22 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 139' ' ' GLU . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.521 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.158 0.504 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.521 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.659 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 4.3 t60 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 117' ' ' THR . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.659 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.72 ' C ' ' H ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.549 ' H ' ' CG2' ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.72 ' H ' ' C ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.56 ' H ' ' C ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 145' ' ' MET . 14.1 tmm? . . . . . 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.935 0.398 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 133' ' ' ASP . 98.9 mm-40 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.708 0.289 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.641 ' CG ' ' H ' ' A' ' 140' ' ' GLU . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.641 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.996 0.426 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.58 ' CZ ' ' HH ' ' A' ' 138' ' ' TYR . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HZ2' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.648 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.648 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.616 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.414 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.652 ' N ' ' HZ2' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.497 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.418 ' OG1' ' OE2' ' A' ' 120' ' ' GLU . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.616 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.58 ' HH ' ' CZ ' ' A' ' 90' ' ' ARG . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.982 0.42 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.411 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.411 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.478 ' ND1' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.5 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 141' ' ' PHE . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' CD ' ' C ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.503 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.448 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.517 ' N ' ' O ' ' A' ' 142' ' ' VAL . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.551 ' NH2' ' HH ' ' A' ' 138' ' ' TYR . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.599 ' CB ' HE22 ' A' ' 135' ' ' GLN . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.746 ' O ' ' N ' ' A' ' 132' ' ' GLY . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.631 ' H ' ' CG2' ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.599 HE22 ' CB ' ' A' ' 101' ' ' SER . 98.4 mm-40 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HH ' ' NH2' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.552 ' HG1' ' CB ' ' A' ' 120' ' ' GLU . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' CB ' ' HG1' ' A' ' 117' ' ' THR . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.481 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.651 ' H ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.498 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 141' ' ' PHE . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 145' ' ' MET . 13.8 tmm? . . . . . 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.412 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.465 ' CD2' ' HZ1' ' A' ' 94' ' ' LYS . 25.9 t60 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.65 HD22 ' H ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.65 ' H ' HD22 ' A' ' 137' ' ' ASN . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 141' ' ' PHE . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.576 ' HG ' ' H ' ' A' ' 102' ' ' ALA . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' H ' ' HG ' ' A' ' 101' ' ' SER . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.589 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 6.9 t60 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.935 0.398 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' A' ' 84' ' ' GLU . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.2 m120 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.593 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 105' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.576 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 144' ' ' MET . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.563 ' H ' ' C ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -119.72 5.16 11.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.739 0.304 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.66 -45.7 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 83' ' ' GLU . 51.4 p -164.52 -20.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -52.02 -15.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.047 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' N ' ' C ' ' A' ' 81' ' ' SER . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.649 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 144' ' ' MET . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.549 ' H ' ' C ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm -36.81 -47.2 0.66 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 148' ' ' LYS . 8.7 m -67.49 -56.76 8.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.54 80.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.223 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 146' ' ' THR . 64.3 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.062 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' SER . 8.9 t -169.74 -146.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' OG1' ' A' ' 79' ' ' THR . 46.7 t0 -71.75 21.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' THR . 10.6 p -73.09 171.86 12.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.47 -17.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.539 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' SER . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.659 ' HE ' ' HH ' ' A' ' 138' ' ' TYR . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.659 ' HH ' ' HE ' ' A' ' 90' ' ' ARG . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.495 ' O ' ' N ' ' A' ' 146' ' ' THR . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp 41.74 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 144' ' ' MET . 14.7 p -139.11 13.52 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.336 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 131.96 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.968 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.58 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.2 p30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.5 m -132.64 126.26 32.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.577 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 36.9 p-10 -89.04 -7.22 56.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.442 ' C ' ' N ' ' A' ' 83' ' ' GLU . 1.4 t 76.89 71.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -49.45 -15.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.24 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 81' ' ' SER . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.548 ' ND2' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.502 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.567 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm -43.6 -61.2 1.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -120.04 51.46 1.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.85 109.16 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.272 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.385 -179.682 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ASP . 33.8 p 41.89 72.67 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 62.9 t0 -31.09 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.476 0.485 . . . . 0.0 111.025 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.463 ' C ' ' N ' ' A' ' 83' ' ' GLU . 31.6 p -172.09 -9.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 109.976 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.55 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.49 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' C ' ' A' ' 81' ' ' SER . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 96' ' ' GLY . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' ND2' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.445 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.805 HD22 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.563 ' N ' HD21 ' A' ' 137' ' ' ASN . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.805 ' H ' HD22 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 139' ' ' GLU . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm -32.31 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 m -76.66 -51.99 10.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.8 146.19 14.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.388 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p 40.85 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.734 0.302 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -92.23 -25.82 18.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 83' ' ' GLU . 22.3 m 52.17 84.93 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.014 0.435 . . . . 0.0 110.477 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 -48.7 -14.99 0.07 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.039 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 81' ' ' SER . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.521 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.659 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 4.3 t60 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 117' ' ' THR . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.659 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 147' ' ' ALA . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp -40.88 -67.25 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -90.17 -60.33 1.96 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.295 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 143' ' ' GLN . . . -49.57 111.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 79' ' ' THR . 49.1 p30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 20.8 m -73.42 -48.96 29.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.0 -71.3 0.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.852 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 169.99 55.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -44.86 -33.65 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.72 ' C ' ' H ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.549 ' H ' ' CG2' ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.72 ' H ' ' C ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.56 ' H ' ' C ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 145' ' ' MET . 14.1 tmm? -70.89 -6.52 38.93 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -138.86 51.45 1.81 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.357 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.34 136.35 58.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.435 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.726 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 t -153.15 156.69 39.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.64 0.257 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' SER . 96.7 m-20 -59.84 -67.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' ASP . 79.7 p 35.63 -142.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.425 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -60.01 -14.03 14.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.405 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 133' ' ' ASP . 98.9 mm-40 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm -43.76 -111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -131.91 22.55 4.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.417 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.77 83.63 2.78 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.301 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 10.2 t -141.72 -155.51 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -91.48 -47.72 7.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.641 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' ASP . 32.5 t 28.76 -83.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.737 0.648 . . . . 0.0 111.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.0 tt0 -49.3 -45.9 45.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.641 ' CG ' ' H ' ' A' ' 140' ' ' GLU . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.641 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp -68.9 149.43 48.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.99 -0.87 3.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.453 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.86 136.3 53.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.157 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.249 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.3 m -67.4 -2.56 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.757 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 34.5 p-10 -118.93 -8.21 10.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 83' ' ' GLU . 26.5 t -96.55 114.49 26.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -45.32 -15.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' SER . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.58 ' CZ ' ' HH ' ' A' ' 138' ' ' TYR . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HZ2' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.648 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.648 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.616 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.414 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.652 ' N ' ' HZ2' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.497 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.418 ' OG1' ' OE2' ' A' ' 120' ' ' GLU . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.616 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.58 ' HH ' ' CZ ' ' A' ' 90' ' ' ARG . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp -59.76 135.9 57.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.4 p -78.31 47.29 0.68 Allowed 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.44 96.29 7.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.914 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.716 179.718 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -122.27 53.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 82' ' ' GLU . 97.8 m-20 -50.69 -49.1 58.24 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.695 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 70.16 -49.09 0.64 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.132 0.491 . . . . 0.0 110.835 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' ASP . 80.8 tt0 -42.64 -42.41 3.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.502 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.411 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.411 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.478 ' ND1' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.5 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 141' ' ' PHE . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.8 ttp -59.44 142.42 52.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.1 p -109.09 -6.5 15.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.707 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.3 151.14 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.196 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.501 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -99.76 -60.66 1.49 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.716 0.293 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -76.72 -13.25 60.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -59.29 -55.7 31.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -53.83 -36.11 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' CD ' ' C ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.448 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.517 ' N ' ' O ' ' A' ' 142' ' ' VAL . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp -54.18 134.1 44.44 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.3 m -99.9 -30.16 12.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.79 138.9 17.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.76 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.0 p -93.78 82.32 4.29 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.312 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -90.05 7.44 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.344 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 83' ' ' GLU . 23.0 t -93.77 51.72 1.59 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.396 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -44.75 -19.75 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.373 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 81' ' ' SER . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.551 ' NH2' ' HH ' ' A' ' 138' ' ' TYR . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.599 ' CB ' HE22 ' A' ' 135' ' ' GLN . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.746 ' O ' ' N ' ' A' ' 132' ' ' GLY . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.631 ' H ' ' CG2' ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.599 HE22 ' CB ' ' A' ' 101' ' ' SER . 98.4 mm-40 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HH ' ' NH2' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp -60.5 139.21 57.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -64.37 -47.19 80.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.03 53.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.43 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER -149.65 26.74 0.83 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.518 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -79.98 -3.38 48.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 53.6 p -79.66 -58.1 3.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' N ' ' OG ' ' A' ' 81' ' ' SER . 82.9 tt0 -49.39 -20.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.552 ' HG1' ' CB ' ' A' ' 120' ' ' GLU . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' CB ' ' HG1' ' A' ' 117' ' ' THR . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.481 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm -45.87 -125.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.407 ' H ' ' CG ' ' A' ' 145' ' ' MET . 46.3 p -138.16 34.63 2.33 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.481 -0.762 . . . . 0.0 110.428 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.57 93.57 8.6 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.099 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.056 -179.576 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p 39.8 76.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.614 0.245 . . . . 0.0 110.886 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.42 -34.25 77.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' GLU . 9.6 t -63.95 -57.02 11.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -39.42 -27.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.538 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' SER . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.651 ' H ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.498 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 141' ' ' PHE . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.01 148.87 46.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.2 m -135.93 -7.9 2.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.2 131.04 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.156 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 117.684 -1.151 . . . . 0.0 109.318 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 66.1 t0 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.7 p -126.18 11.59 7.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.718 0.294 . . . . 0.0 110.681 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.416 ' O ' ' OG ' ' A' ' 81' ' ' SER . 99.1 m-20 -57.37 -46.18 83.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 72.1 m -170.1 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.292 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -42.28 -37.71 1.59 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.444 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 146' ' ' THR . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 145' ' ' MET . 13.8 tmm? -73.47 -8.44 55.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 143' ' ' GLN . 2.7 m -137.58 44.5 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.869 0.366 . . . . 0.0 110.74 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.09 138.16 31.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.168 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.827 -179.559 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.9 m-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 p -80.22 24.68 0.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 110.456 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 81' ' ' SER . 36.2 t70 -82.97 5.8 20.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.644 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 83' ' ' GLU . 3.6 p 86.07 10.05 0.25 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.193 0.52 . . . . 0.0 110.741 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -56.58 -2.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.22 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.576 ' H ' ' C ' ' A' ' 81' ' ' SER . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.412 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.465 ' CD2' ' HZ1' ' A' ' 94' ' ' LYS . 25.9 t60 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.65 HD22 ' H ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.65 ' H ' HD22 ' A' ' 137' ' ' ASN . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 141' ' ' PHE . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp -43.38 126.96 4.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 p -135.24 54.82 1.91 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.723 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.61 159.9 23.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.503 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.1 m -130.17 121.18 25.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' A' ' 81' ' ' SER . 80.1 m-20 -73.86 -47.54 37.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 24.9 p 59.49 81.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.083 0.468 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.97 -15.91 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.447 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm -42.46 -68.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.7 m -115.28 49.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 110.672 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.8 141.7 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.218 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.015 -179.492 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.9 m -132.76 124.82 28.81 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.0 -6.96 53.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.692 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 84' ' ' GLU . 46.7 t 47.01 82.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -45.64 -32.7 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.369 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 81' ' ' SER . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.576 ' HG ' ' H ' ' A' ' 102' ' ' ALA . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' H ' ' HG ' ' A' ' 101' ' ' SER . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.589 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 6.9 t60 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm -36.72 114.38 0.3 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -91.23 -41.17 11.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.669 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.43 127.25 21.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.357 -179.698 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 81' ' ' SER . 21.4 p 39.83 75.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.668 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -77.22 16.86 0.53 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 83' ' ' GLU . 78.8 p -123.39 -65.71 1.06 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' N ' ' OG ' ' A' ' 81' ' ' SER . 80.7 tt0 -45.76 -15.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.588 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 81' ' ' SER . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.2 m120 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 102' ' ' ALA . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.593 ' N ' ' HG ' ' A' ' 101' ' ' SER . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 105' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.576 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 144' ' ' MET . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.563 ' H ' ' C ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp -64.19 151.62 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.6 p -113.7 -12.15 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.236 0.335 . . . . 0.0 110.627 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.42 147.43 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 tttp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.614 179.729 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 8.0 p30 -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' VAL . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 33.5 m170 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.505 HD12 ' CA ' ' A' ' 102' ' ' ALA . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.413 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 108' ' ' VAL . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 104' ' ' GLU . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' CG1' ' A' ' 136' ' ' VAL . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.685 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.952 0.406 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 28.3 p30 -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' HG13 ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.533 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.936 0.398 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 92' ' ' PHE . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 8.3 p-10 -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' HD21 ' A' ' 105' ' ' LEU . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD21 ' CG2' ' A' ' 100' ' ' ILE . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 136' ' ' VAL . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.71 HD22 ' HG3' ' A' ' 140' ' ' GLU . 24.4 p30 -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.55 ' O ' HG23 ' A' ' 142' ' ' VAL . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.71 ' HG3' HD22 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.158 0.504 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.678 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 21.1 t-80 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 102' ' ' ALA . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.69 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.69 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 108' ' ' VAL . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.5 HG23 ' CG1' ' A' ' 136' ' ' VAL . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.671 ' N ' HG22 ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.535 ' N ' ' O ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 145' ' ' MET . 14.1 tmm? . . . . . 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.935 0.398 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.748 ' C ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 102' ' ' ALA . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 133' ' ' ASP . 30.8 mm100 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.708 0.289 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.445 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 104' ' ' GLU . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 108' ' ' VAL . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 121' ' ' VAL . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD23 ' A' ' 116' ' ' LEU . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 141' ' ' PHE . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.578 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.996 0.426 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 24.2 p-10 -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.656 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.634 ' N ' ' NZ ' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 102' ' ' ALA . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.445 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.568 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.656 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.467 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.982 0.42 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.444 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' CE2' ' A' ' 141' ' ' PHE . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 108' ' ' VAL . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 120' ' ' GLU . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 102' ' ' ALA . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 142' ' ' VAL . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' CD ' ' C ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 108' ' ' VAL . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.463 ' CG2' HD21 ' A' ' 105' ' ' LEU . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' HG12 ' A' ' 108' ' ' VAL . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.463 HD21 ' CG2' ' A' ' 100' ' ' ILE . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.482 ' N ' HG13 ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 ' CG2' ' A' ' 136' ' ' VAL . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.495 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD12 ' CA ' ' A' ' 102' ' ' ALA . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 131' ' ' ASP . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.779 ' H ' HG22 ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 30.8 mm100 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.56 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.482 ' HB3' HD23 ' A' ' 116' ' ' LEU . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' MET . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 124' ' ' MET . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' HB1' ' A' ' 102' ' ' ALA . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 102' ' ' ALA . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.525 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 85' ' ' ILE . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 141' ' ' PHE . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.779 ' C ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.595 ' N ' HD22 ' A' ' 116' ' ' LEU . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 HD23 ' A' ' 116' ' ' LEU . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 121' ' ' VAL . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 136' ' ' VAL . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.457 ' CG2' HG23 ' A' ' 125' ' ' ILE . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 138' ' ' TYR . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.536 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 112' ' ' LEU . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.601 HG23 HG23 ' A' ' 136' ' ' VAL . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 HG23 ' A' ' 125' ' ' ILE . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 145' ' ' MET . 13.8 tmm? . . . . . 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 141' ' ' PHE . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 108' ' ' VAL . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 106' ' ' ARG . 51.3 t-80 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 102' ' ' ALA . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.544 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.556 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 141' ' ' PHE . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.529 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.529 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 102' ' ' ALA . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 135' ' ' GLN . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.438 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.469 HG21 ' CE2' ' A' ' 141' ' ' PHE . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 108' ' ' VAL . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 116' ' ' LEU . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' CA ' ' A' ' 102' ' ' ALA . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.935 0.398 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' A' ' 84' ' ' GLU . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 84.5 m-20 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.645 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' SD ' ' A' ' 109' ' ' MET . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 136' ' ' VAL . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 125' ' ' ILE . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' GLU . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.72 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -119.72 5.16 11.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.739 0.304 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.66 -45.7 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 83' ' ' GLU . 51.4 p -164.52 -20.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -52.02 -15.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.047 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' N ' ' C ' ' A' ' 81' ' ' SER . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 8.0 p30 -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' VAL . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 33.5 m170 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.505 HD12 ' CA ' ' A' ' 102' ' ' ALA . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm -36.81 -47.2 0.66 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 148' ' ' LYS . 8.7 m -67.49 -56.76 8.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.54 80.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.223 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 146' ' ' THR . 64.3 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.062 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 81' ' ' SER . 8.9 t -169.74 -146.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' OG1' ' A' ' 79' ' ' THR . 46.7 t0 -71.75 21.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 79' ' ' THR . 10.6 p -73.09 171.86 12.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.47 -17.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.539 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' SER . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.413 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 108' ' ' VAL . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 104' ' ' GLU . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' CG1' ' A' ' 136' ' ' VAL . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.685 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp 41.74 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 144' ' ' MET . 14.7 p -139.11 13.52 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.336 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 131.96 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.968 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.58 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.2 p30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 81' ' ' SER . 97.5 m -132.64 126.26 32.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.577 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 36.9 p-10 -89.04 -7.22 56.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.52 ' H ' HG22 ' A' ' 79' ' ' THR . 1.4 t 76.89 71.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -49.45 -15.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.24 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 81' ' ' SER . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 28.3 p30 -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' HG13 ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.533 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm -43.6 -61.2 1.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -120.04 51.46 1.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.85 109.16 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.272 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.385 -179.682 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ASP . 33.8 p 41.89 72.67 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 62.9 t0 -31.09 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.476 0.485 . . . . 0.0 111.025 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.463 ' C ' ' N ' ' A' ' 83' ' ' GLU . 31.6 p -172.09 -9.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 109.976 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' SER . 84.4 tt0 -45.55 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.49 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' C ' ' A' ' 81' ' ' SER . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 92' ' ' PHE . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 8.3 p-10 -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' HD21 ' A' ' 105' ' ' LEU . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD21 ' CG2' ' A' ' 100' ' ' ILE . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 136' ' ' VAL . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.71 HD22 ' HG3' ' A' ' 140' ' ' GLU . 24.4 p30 -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.55 ' O ' HG23 ' A' ' 142' ' ' VAL . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.71 ' HG3' HD22 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm -32.31 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 m -76.66 -51.99 10.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.8 146.19 14.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.388 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p 40.85 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.734 0.302 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -92.23 -25.82 18.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 83' ' ' GLU . 22.3 m 52.17 84.93 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.014 0.435 . . . . 0.0 110.477 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 -48.7 -14.99 0.07 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.039 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 81' ' ' SER . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.678 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 21.1 t-80 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 102' ' ' ALA . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.69 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.684 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.69 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp -40.88 -67.25 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -90.17 -60.33 1.96 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.295 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -49.57 111.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 79' ' ' THR . 49.1 p30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 20.8 m -73.42 -48.96 29.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.0 -71.3 0.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.852 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 169.99 55.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -44.86 -33.65 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 108' ' ' VAL . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.5 HG23 ' CG1' ' A' ' 136' ' ' VAL . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.671 ' N ' HG22 ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.535 ' N ' ' O ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 145' ' ' MET . 14.1 tmm? -70.89 -6.52 38.93 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -138.86 51.45 1.81 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.357 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.34 136.35 58.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.435 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.726 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 t -153.15 156.69 39.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.64 0.257 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' SER . 96.7 m-20 -59.84 -67.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' ASP . 79.7 p 35.63 -142.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.425 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -60.01 -14.03 14.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.405 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.748 ' C ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 102' ' ' ALA . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 133' ' ' ASP . 30.8 mm100 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm -43.76 -111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -131.91 22.55 4.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.417 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.77 83.63 2.78 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.301 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 10.2 t -141.72 -155.51 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -91.48 -47.72 7.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.641 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' ASP . 32.5 t 28.76 -83.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.737 0.648 . . . . 0.0 111.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.0 tt0 -49.3 -45.9 45.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.445 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 104' ' ' GLU . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 108' ' ' VAL . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 121' ' ' VAL . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD23 ' A' ' 116' ' ' LEU . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 141' ' ' PHE . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.578 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp -68.9 149.43 48.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.99 -0.87 3.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.453 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.86 136.3 53.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.157 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.249 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 79' ' ' THR . 66.3 m -67.4 -2.56 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.757 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 34.5 p-10 -118.93 -8.21 10.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 83' ' ' GLU . 26.5 t -96.55 114.49 26.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -45.32 -15.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' SER . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 24.2 p-10 -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.656 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.634 ' N ' ' NZ ' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 102' ' ' ALA . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.445 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.568 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.656 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.467 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp -59.76 135.9 57.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.4 p -78.31 47.29 0.68 Allowed 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.44 96.29 7.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.914 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.716 179.718 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -122.27 53.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -50.69 -49.1 58.24 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 70.16 -49.09 0.64 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.132 0.491 . . . . 0.0 110.835 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -42.64 -42.41 3.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.502 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.444 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' CE2' ' A' ' 141' ' ' PHE . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 108' ' ' VAL . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 120' ' ' GLU . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 102' ' ' ALA . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 142' ' ' VAL . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.426 ' HG2' ' H ' ' A' ' 147' ' ' ALA . 59.8 ttp -59.44 142.42 52.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.1 p -109.09 -6.5 15.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.707 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 145' ' ' MET . . . -64.3 151.14 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.196 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.501 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -99.76 -60.66 1.49 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.716 0.293 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -76.72 -13.25 60.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -59.29 -55.7 31.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -53.83 -36.11 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' CD ' ' C ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 108' ' ' VAL . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' CG2' HD21 ' A' ' 105' ' ' LEU . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' HG12 ' A' ' 108' ' ' VAL . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.463 HD21 ' CG2' ' A' ' 100' ' ' ILE . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.482 ' N ' HG13 ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 ' CG2' ' A' ' 136' ' ' VAL . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp -54.18 134.1 44.44 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.3 m -99.9 -30.16 12.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.79 138.9 17.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.76 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.0 p -93.78 82.32 4.29 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.312 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -90.05 7.44 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.344 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 83' ' ' GLU . 23.0 t -93.77 51.72 1.59 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.396 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -44.75 -19.75 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.373 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 81' ' ' SER . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD12 ' CA ' ' A' ' 102' ' ' ALA . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 131' ' ' ASP . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.779 ' H ' HG22 ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 30.8 mm100 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp -60.5 139.21 57.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -64.37 -47.19 80.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.03 53.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.43 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 79' ' ' THR . 0.6 OUTLIER -149.65 26.74 0.83 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.518 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -79.98 -3.38 48.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 53.6 p -79.66 -58.1 3.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' N ' ' OG ' ' A' ' 81' ' ' SER . 82.9 tt0 -49.39 -20.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.56 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.482 ' HB3' HD23 ' A' ' 116' ' ' LEU . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' MET . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 124' ' ' MET . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' HB1' ' A' ' 102' ' ' ALA . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 102' ' ' ALA . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.525 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm -45.87 -125.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.3 p -138.16 34.63 2.33 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.481 -0.762 . . . . 0.0 110.428 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.57 93.57 8.6 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.099 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.056 -179.576 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p 39.8 76.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.614 0.245 . . . . 0.0 110.886 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.42 -34.25 77.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' GLU . 9.6 t -63.95 -57.02 11.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -39.42 -27.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.538 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' SER . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 85' ' ' ILE . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 141' ' ' PHE . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.779 ' C ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.595 ' N ' HD22 ' A' ' 116' ' ' LEU . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 HD23 ' A' ' 116' ' ' LEU . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 121' ' ' VAL . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 136' ' ' VAL . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.457 ' CG2' HG23 ' A' ' 125' ' ' ILE . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 138' ' ' TYR . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.01 148.87 46.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 146' ' ' THR . 25.2 m -135.93 -7.9 2.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.2 131.04 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.156 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 117.684 -1.151 . . . . 0.0 109.318 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 66.1 t0 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.7 p -126.18 11.59 7.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.718 0.294 . . . . 0.0 110.681 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' O ' ' OG ' ' A' ' 81' ' ' SER . 99.1 m-20 -57.37 -46.18 83.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 72.1 m -170.1 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.292 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -42.28 -37.71 1.59 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.444 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.536 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 112' ' ' LEU . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.601 HG23 HG23 ' A' ' 136' ' ' VAL . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 HG23 ' A' ' 125' ' ' ILE . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 146' ' ' THR . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.528 ' SD ' ' O ' ' A' ' 145' ' ' MET . 13.8 tmm? -73.47 -8.44 55.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 143' ' ' GLN . 2.7 m -137.58 44.5 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.869 0.366 . . . . 0.0 110.74 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.09 138.16 31.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.168 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.827 -179.559 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 p -80.22 24.68 0.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 110.456 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 81' ' ' SER . 36.2 t70 -82.97 5.8 20.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.644 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 83' ' ' GLU . 3.6 p 86.07 10.05 0.25 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.193 0.52 . . . . 0.0 110.741 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -56.58 -2.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.22 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 81' ' ' SER . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 141' ' ' PHE . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 108' ' ' VAL . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 106' ' ' ARG . 51.3 t-80 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 102' ' ' ALA . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.544 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.556 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp -43.38 126.96 4.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 p -135.24 54.82 1.91 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.723 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.61 159.9 23.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.503 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.1 m -130.17 121.18 25.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' A' ' 81' ' ' SER . 80.1 m-20 -73.86 -47.54 37.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 24.9 p 59.49 81.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.083 0.468 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.97 -15.91 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.447 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 81' ' ' SER . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 141' ' ' PHE . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.529 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.529 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 102' ' ' ALA . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 135' ' ' GLN . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.438 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm -42.46 -68.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.7 m -115.28 49.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 110.672 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.8 141.7 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.218 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.015 -179.492 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 81' ' ' SER . 89.9 m -132.76 124.82 28.81 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.0 -6.96 53.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.692 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' THR . 46.7 t 47.01 82.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -45.64 -32.7 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.369 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG21 ' CE2' ' A' ' 141' ' ' PHE . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 108' ' ' VAL . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 116' ' ' LEU . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' CA ' ' A' ' 102' ' ' ALA . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm -36.72 114.38 0.3 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -91.23 -41.17 11.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.669 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.43 127.25 21.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.357 -179.698 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 81' ' ' SER . 21.4 p 39.83 75.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.668 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -77.22 16.86 0.53 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 83' ' ' GLU . 78.8 p -123.39 -65.71 1.06 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' N ' ' OG ' ' A' ' 81' ' ' SER . 80.7 tt0 -45.76 -15.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.588 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 84.5 m-20 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.645 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' SD ' ' A' ' 109' ' ' MET . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 136' ' ' VAL . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 125' ' ' ILE . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' GLU . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.72 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp -64.19 151.62 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.6 p -113.7 -12.15 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.236 0.335 . . . . 0.0 110.627 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.42 147.43 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 tttp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.614 179.729 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.726 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.726 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' VAL . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 61.9 m-70 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.505 HD12 ' CA ' ' A' ' 102' ' ' ALA . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.413 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 108' ' ' VAL . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 104' ' ' GLU . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' CG1' ' A' ' 136' ' ' VAL . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.685 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.952 0.406 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.548 ' ND2' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' HG13 ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.533 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.936 0.398 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 92' ' ' PHE . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.3 OUTLIER -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' HD21 ' A' ' 105' ' ' LEU . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD21 ' CG2' ' A' ' 100' ' ' ILE . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 136' ' ' VAL . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.911 HD21 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.599 ' N ' HD22 ' A' ' 137' ' ' ASN . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.911 ' H ' HD21 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.158 0.504 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.678 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 4.3 t60 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 102' ' ' ALA . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.69 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.69 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 108' ' ' VAL . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.5 HG23 ' CG1' ' A' ' 136' ' ' VAL . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.671 ' N ' HG22 ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.535 ' N ' ' O ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 145' ' ' MET . 14.1 tmm? . . . . . 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.935 0.398 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.492 ' CB ' HE22 ' A' ' 135' ' ' GLN . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 102' ' ' ALA . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 133' ' ' ASP . 98.9 mm-40 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.708 0.289 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.445 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 104' ' ' GLU . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 108' ' ' VAL . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 121' ' ' VAL . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD23 ' A' ' 116' ' ' LEU . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 141' ' ' PHE . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.578 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.996 0.426 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.717 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.717 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.656 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.634 ' N ' ' NZ ' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 102' ' ' ALA . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.445 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.568 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.656 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.467 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.982 0.42 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.444 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' CE2' ' A' ' 141' ' ' PHE . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 108' ' ' VAL . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 120' ' ' GLU . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 102' ' ' ALA . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 142' ' ' VAL . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' C ' ' CD ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 108' ' ' VAL . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.583 ' C ' HD22 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.558 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.543 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.463 ' CG2' HD21 ' A' ' 105' ' ' LEU . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' HG12 ' A' ' 108' ' ' VAL . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.463 HD21 ' CG2' ' A' ' 100' ' ' ILE . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.482 ' N ' HG13 ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 ' CG2' ' A' ' 136' ' ' VAL . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.495 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.641 ' CB ' HE22 ' A' ' 135' ' ' GLN . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD12 ' CA ' ' A' ' 102' ' ' ALA . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 131' ' ' ASP . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.779 ' H ' HG22 ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.641 HE22 ' CB ' ' A' ' 101' ' ' SER . 98.4 mm-40 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.56 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.482 ' HB3' HD23 ' A' ' 116' ' ' LEU . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' MET . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 124' ' ' MET . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' HB1' ' A' ' 102' ' ' ALA . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 102' ' ' ALA . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.525 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 85' ' ' ILE . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 141' ' ' PHE . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.779 HD22 ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.595 ' N ' HD22 ' A' ' 116' ' ' LEU . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 HD23 ' A' ' 116' ' ' LEU . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 121' ' ' VAL . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 136' ' ' VAL . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.457 ' CG2' HG23 ' A' ' 125' ' ' ILE . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 138' ' ' TYR . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.536 ' C ' ' HD1' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 112' ' ' LEU . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.601 HG23 HG23 ' A' ' 136' ' ' VAL . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 HG23 ' A' ' 125' ' ' ILE . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 145' ' ' MET . 13.8 tmm? . . . . . 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 141' ' ' PHE . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 108' ' ' VAL . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 106' ' ' ARG . 25.9 t60 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 102' ' ' ALA . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.544 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.755 HD21 ' H ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.755 ' H ' HD21 ' A' ' 137' ' ' ASN . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.556 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 141' ' ' PHE . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.529 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.529 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 102' ' ' ALA . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 135' ' ' GLN . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.438 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.469 HG21 ' CE2' ' A' ' 141' ' ' PHE . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 108' ' ' VAL . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.589 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 6.9 t60 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 116' ' ' LEU . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' CA ' ' A' ' 102' ' ' ALA . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.935 0.398 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' A' ' 84' ' ' GLU . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.2 m120 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.732 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.645 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' SD ' ' A' ' 109' ' ' MET . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 136' ' ' VAL . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 125' ' ' ILE . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' GLU . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.72 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -119.72 5.16 11.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.739 0.304 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.66 -45.7 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 83' ' ' GLU . 51.4 p -164.52 -20.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -52.02 -15.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.047 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' N ' ' C ' ' A' ' 81' ' ' SER . 81.5 tt0 -65.82 -51.36 59.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.845 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -50.39 -44.79 55.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.302 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.86 -48.63 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.36 -35.27 69.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.351 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 90' ' ' ARG . 98.8 mt-10 -73.94 -68.99 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.345 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.74 -49.85 0.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.089 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.8 -40.4 83.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 87' ' ' GLU . 64.7 mtt-85 -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -67.98 -30.18 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -55.72 -51.35 67.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.0 t0 -48.71 95.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.4 mtpt -53.95 -57.59 10.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.08 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' ASN . 34.3 t70 -74.92 24.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 24.49 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.905 0 O-C-N 123.893 0.745 . . . . 0.0 112.071 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.726 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -74.71 -7.46 53.36 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.359 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 92.68 1.98 67.71 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.726 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 98.4 m-85 -142.69 -171.56 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mm -129.04 128.76 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.785 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' ' NE2' ' A' ' 135' ' ' GLN . 11.1 m -109.73 162.11 14.77 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.13 0.894 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -68.09 -37.53 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.936 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.17 76.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.012 0.434 . . . . 0.0 111.59 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' VAL . 92.3 mt-10 -67.48 -34.18 76.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.129 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.36 -49.69 70.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.243 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 35.1 ptt180 -63.07 -45.55 91.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.943 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 61.9 m-70 -66.91 -51.49 54.73 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.726 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -62.71 -48.86 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.546 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.7 mmt -59.49 -45.94 90.23 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.0 m -62.49 -41.45 98.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -65.59 -36.94 85.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.026 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.13 -35.39 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.802 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.79 -1.96 3.62 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -121.73 114.55 21.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -94.13 99.94 12.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.4 mp -76.7 -170.51 1.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.962 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.0 p -107.3 127.89 53.96 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.042 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -57.39 -36.96 71.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.11 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -62.32 -38.44 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 124' ' ' MET . 98.2 mt-10 -74.97 -48.04 26.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.003 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.98 -66.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -44.9 -43.72 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.962 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.97 -32.03 66.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.008 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.2 tpp -52.62 -67.16 0.27 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.03 0.443 . . . . 0.0 111.404 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.505 HD12 ' CA ' ' A' ' 102' ' ' ALA . 28.2 mt -57.1 -45.51 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.056 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -44.4 -38.74 4.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.592 -178.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.15 -31.42 30.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.95 35.81 1.5 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.741 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.612 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.9 t70 -117.76 115.91 25.96 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.989 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.79 -37.27 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.144 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -84.63 -23.27 29.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.291 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 70.93 39.53 64.08 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 135' ' ' GLN . 36.9 p-10 -124.71 37.94 4.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.306 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.53 14.64 0.22 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.568 ' NE2' ' OG ' ' A' ' 101' ' ' SER . 41.7 mm-40 -134.86 131.6 37.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.21 141.33 44.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.33 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -71.81 -155.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.39 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -75.2 -55.08 6.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.927 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 141' ' ' PHE . 75.2 mt-10 -56.6 -69.34 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.0 mt-10 -31.7 -31.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.118 0.886 . . . . 0.0 109.695 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -83.72 -54.92 4.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.542 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.4 t -38.71 -64.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.003 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -44.03 -15.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 142' ' ' VAL . 5.2 tpt -99.64 -52.01 3.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.035 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.9 ttm -36.81 -47.2 0.66 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.162 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 148' ' ' LYS . 8.7 m -67.49 -56.76 8.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.54 80.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.223 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 146' ' ' THR . 64.3 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.062 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 81' ' ' SER . 8.9 t -169.74 -146.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' OG1' ' A' ' 79' ' ' THR . 46.7 t0 -71.75 21.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 79' ' ' THR . 10.6 p -73.09 171.86 12.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.47 -17.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.539 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' SER . 47.3 tp10 -64.42 -49.87 69.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.33 -46.6 47.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -57.49 -48.1 83.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 78.2 mtp85 -59.4 -39.25 82.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.772 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -76.47 -62.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.189 0.518 . . . . 0.0 111.385 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -40.1 -53.85 2.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.605 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -64.99 -43.75 91.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.359 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.5 mmt85 -54.38 -45.42 72.84 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.99 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.19 -41.49 92.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.707 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -56.33 -52.14 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -56.03 85.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.405 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.2 mptp? -52.3 -54.95 24.95 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -77.33 12.69 1.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 27.58 48.25 0.06 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.922 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.94 -11.32 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.101 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.61 -20.99 33.39 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 38.3 m-85 -134.83 148.39 50.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -80.79 133.59 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -107.45 164.36 12.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.413 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -69.81 -37.11 76.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.625 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -34.8 77.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.039 0.447 . . . . 0.0 111.31 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 108' ' ' VAL . 64.9 mt-10 -65.87 -35.55 80.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.3 mt -66.64 -50.89 61.49 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -62.07 -44.59 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.015 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -58.7 -58.52 8.22 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.83 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 104' ' ' GLU . 12.2 m -64.62 -32.87 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.028 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.6 mmt -59.09 -53.92 52.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.423 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.9 m -63.95 -42.89 97.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.165 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -61.22 -39.13 89.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.006 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.67 -38.72 88.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.322 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.19 -2.81 3.97 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -113.45 106.59 14.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.725 0.297 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -84.47 91.69 7.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.06 0.457 . . . . 0.0 110.695 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.29 -172.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.103 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.9 p -107.02 124.31 49.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.137 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -57.44 -32.29 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.528 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.63 -37.15 86.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.53 -46.95 35.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.84 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -51.65 -65.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -47.85 -40.01 20.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.835 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.28 -39.63 78.23 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.295 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.8 mmt -52.89 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.466 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' CG1' ' A' ' 136' ' ' VAL . 20.4 mt -59.3 -42.98 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 109.961 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -50.24 -40.68 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.67 -45.92 23.5 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.943 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.1 -51.49 66.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.1 0.476 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 7.8 t0 -43.65 127.06 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.503 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.5 mt -100.11 -26.93 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.043 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -91.69 -17.4 25.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 67.26 36.72 90.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 135' ' ' GLN . 21.9 p-10 -105.7 36.81 2.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 111.387 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.38 7.4 0.23 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 133' ' ' ASP . 47.7 mt-30 -147.51 154.28 40.56 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.724 -0.28 . . . . 0.0 110.276 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.19 148.22 27.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.912 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -65.05 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 42.0 m-85 -77.91 -53.59 7.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.3 mm-40 -58.94 -65.9 0.59 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.446 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.3 mt-10 -32.86 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.095 0.872 . . . . 0.0 109.472 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -86.23 -54.52 4.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.176 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' GLU . 53.5 t -33.29 -59.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.379 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -42.14 -68.05 0.22 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.857 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.685 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.9 mmt -60.28 -51.8 68.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.589 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.9 tpp 41.74 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.74 0.305 . . . . 0.0 111.145 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 144' ' ' MET . 14.7 p -139.11 13.52 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.336 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 131.96 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.968 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.58 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.2 p30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 81' ' ' SER . 97.5 m -132.64 126.26 32.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.577 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 36.9 p-10 -89.04 -7.22 56.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.52 ' H ' HG22 ' A' ' 79' ' ' THR . 1.4 t 76.89 71.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -49.45 -15.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.24 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 81' ' ' SER . 97.1 mt-10 -65.43 -50.0 67.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.018 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -50.51 -46.38 57.12 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.91 -48.43 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.27 -36.25 70.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ARG . 80.8 mm-40 -74.18 -67.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.298 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.66 -51.94 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.765 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -64.65 -42.58 95.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.07 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' GLU . 66.7 mtt-85 -56.45 -44.46 80.52 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.496 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.69 -40.63 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.009 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.0 m-85 -58.83 -50.88 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.486 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 66.5 t0 -46.68 93.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 92' ' ' PHE . 4.7 tptp -52.02 -57.25 10.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.333 0.587 . . . . 0.0 110.24 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.2 m-20 -71.95 9.82 0.85 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.55 52.0 0.22 Allowed Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.852 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.548 ' ND2' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -104.68 11.22 34.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 75.7 33.46 51.6 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.77 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -154.31 160.67 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.0 mm -122.17 123.64 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -107.63 162.57 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.985 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -70.25 -37.3 74.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.165 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.11 81.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 111.38 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -67.53 -32.58 73.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.07 -48.18 79.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.432 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' O ' ' OG1' ' A' ' 110' ' ' THR . 14.3 ptm180 -66.4 -42.86 87.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -66.81 -50.71 61.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.573 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 109' ' ' MET . 4.0 p -64.0 -49.23 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' HG13 ' A' ' 108' ' ' VAL . 81.9 mmm -60.54 -46.17 91.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.041 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 94.7 m -62.48 -39.14 92.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -69.86 -37.47 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.371 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.59 -34.45 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.045 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.85 -12.87 13.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -71.4 157.21 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.502 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -111.85 137.56 49.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -155.02 168.06 28.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.413 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 p -98.54 123.36 42.66 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 27.4 p-10 -54.91 -44.45 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 28.3 mt-10 -58.38 -29.43 66.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.451 . . . . 0.0 110.481 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 124' ' ' MET . 85.1 tt0 -75.55 -42.57 51.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.638 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.32 -69.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.051 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -44.95 -45.32 10.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.135 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.07 -29.52 66.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.152 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 tpt -54.87 -68.27 0.2 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.559 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.6 mt -57.28 -43.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.986 0.422 . . . . 0.0 109.926 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -45.55 -41.16 9.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.662 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -52.45 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -59.95 -49.59 77.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 4.3 t70 -39.33 117.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.331 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.9 mt -97.31 -31.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.924 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -80.91 -23.88 38.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 69.24 39.28 82.44 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 16.7 p-10 -103.18 -28.31 12.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.589 0.233 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.8 9.89 8.01 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -147.69 155.53 41.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 110.432 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -137.94 144.91 29.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 5.7 t-20 -72.6 -153.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.025 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 5.0 m-85 -77.22 -55.27 5.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 141' ' ' PHE . 94.0 mt-10 -56.54 -68.43 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.765 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.533 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 93.1 mt-10 -32.36 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.434 1.084 . . . . 0.0 109.346 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -84.84 -54.44 4.68 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.578 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 139' ' ' GLU . 55.3 t -36.99 -62.32 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -43.37 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.227 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 142' ' ' VAL . 51.0 mmm -93.98 -51.3 4.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.771 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.3 mtm -43.6 -61.2 1.46 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.021 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -120.04 51.46 1.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.85 109.16 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.272 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.385 -179.682 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ASP . 33.8 p 41.89 72.67 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 62.9 t0 -31.09 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.476 0.485 . . . . 0.0 111.025 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.463 ' C ' ' N ' ' A' ' 83' ' ' GLU . 31.6 p -172.09 -9.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 109.976 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' SER . 84.4 tt0 -45.55 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.49 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' C ' ' A' ' 81' ' ' SER . 71.1 mm-40 -64.86 -51.18 63.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.872 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -48.11 -47.54 34.34 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.168 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.76 -49.42 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -57.07 -38.19 72.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.643 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.89 -67.21 0.66 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.17 0.51 . . . . 0.0 111.407 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.31 -54.03 1.08 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.989 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.2 -41.24 94.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -55.38 -45.69 76.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.737 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.7 -43.05 98.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -50.13 -55.24 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.784 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 41.7 t0 -48.72 91.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 92' ' ' PHE . 12.7 tptt -50.94 -56.48 12.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.393 0.616 . . . . 0.0 110.052 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' GLY . 92.6 m-20 -69.61 11.54 0.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.02 50.02 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.917 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.3 OUTLIER -100.4 12.52 37.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.7 0.25 . . . . 0.0 111.604 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.93 37.2 83.24 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 46.9 m-85 -158.61 167.95 28.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' HD21 ' A' ' 105' ' ' LEU . 49.4 mm -121.08 116.79 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -102.71 158.72 16.05 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.757 0.66 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.3 -39.12 93.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.0 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.69 73.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.593 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -36.83 79.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.132 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD21 ' CG2' ' A' ' 100' ' ' ILE . 27.1 mt -64.35 -52.46 58.28 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.434 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 34.3 ptt180 -61.28 -46.33 90.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.035 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 65.1 t-80 -64.35 -53.07 54.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -62.04 -46.38 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -58.15 -48.17 81.08 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.59 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 m -63.65 -44.27 94.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.971 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.82 -39.23 91.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.27 0.557 . . . . 0.0 110.411 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -2.37 3.63 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -118.33 109.69 16.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -86.38 96.03 9.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.38 -172.32 1.73 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.903 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 p -111.12 128.68 55.96 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.137 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.83 -35.54 64.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.492 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.21 -37.84 88.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.2 mt-10 -75.75 -50.35 15.52 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.14 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.2 -66.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -45.28 -44.52 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -71.25 -32.23 68.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.291 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.511 ' N ' ' O ' ' A' ' 120' ' ' GLU . 40.6 ttm -50.89 -66.65 0.35 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.225 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 136' ' ' VAL . 31.8 mt -56.33 -43.5 77.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 1.3 mmp_? -52.41 -40.37 62.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -84.51 -38.73 19.7 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.599 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.17 -55.7 17.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 40.0 t0 -43.57 132.13 4.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 56.4 mt -90.74 -32.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.682 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.3 m-20 -92.07 -5.72 52.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.033 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.21 60.32 6.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 7.3 p-10 -119.04 -30.99 4.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.617 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.72 -1.46 12.19 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -121.2 120.38 35.04 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.2 t -110.1 126.67 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.649 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.911 HD21 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -68.81 -152.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.91 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.599 ' N ' HD22 ' A' ' 137' ' ' ASN . 40.6 m-85 -84.55 -55.98 3.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.463 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 141' ' ' PHE . 80.9 mm-40 -58.9 -68.67 0.24 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.27 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.911 ' H ' HD21 ' A' ' 137' ' ' ASN . 95.9 mt-10 -31.73 -30.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.157 0.911 . . . . 0.0 109.803 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.0 t80 -89.28 -54.1 4.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.821 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.4 t -37.49 -62.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.735 0.303 . . . . 0.0 110.999 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -42.42 -70.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.035 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.419 ' O ' ' C ' ' A' ' 145' ' ' MET . 51.7 mmm -42.31 -47.5 4.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.689 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 144' ' ' MET . 9.8 ttm -32.31 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.471 0.482 . . . . 0.0 111.171 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 m -76.66 -51.99 10.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.8 146.19 14.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.388 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p 40.85 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.734 0.302 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -92.23 -25.82 18.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 83' ' ' GLU . 22.3 m 52.17 84.93 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.014 0.435 . . . . 0.0 110.477 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' CD ' HH12 ' A' ' 86' ' ' ARG . 64.3 tt0 -48.7 -14.99 0.07 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.039 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 81' ' ' SER . 81.1 tt0 -65.94 -49.24 68.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -48.35 -47.06 37.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.171 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.42 -48.7 68.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' A' ' 82' ' ' GLU . 45.1 mtt85 -58.12 -36.64 73.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.96 -67.52 0.67 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 111.335 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.75 -53.9 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.91 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 23.8 m-85 -64.47 -43.53 93.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.252 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -55.92 -44.43 78.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.592 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.08 -42.37 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.276 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -55.85 -51.74 66.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.6 t0 -48.05 92.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' NZ ' ' CG ' ' A' ' 107' ' ' HIS . 55.7 mtpt -57.91 -61.89 2.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.396 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 97' ' ' ASN . 96.8 m-20 -73.13 21.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.443 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.46 42.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.812 0.695 . . . . 0.0 111.892 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.527 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 53.2 p-10 -75.69 2.31 12.34 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.643 -0.327 . . . . 0.0 111.375 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 82.24 1.39 90.37 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -140.03 -172.94 3.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.678 ' N ' HE22 ' A' ' 135' ' ' GLN . 48.2 mm -127.14 125.8 66.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 167.22 9.88 Favored 'General case' 0 C--N 1.353 0.722 0 O-C-N 124.189 0.93 . . . . 0.0 109.828 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -75.61 -36.42 60.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.85 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -35.49 78.01 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 89.0 mt-10 -67.0 -31.85 72.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.167 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.01 -49.95 70.4 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.524 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -63.42 -46.33 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.145 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.576 ' CG ' ' NZ ' ' A' ' 94' ' ' LYS . 4.3 t60 -67.54 -51.91 45.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.8 p -59.2 -49.15 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.452 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.6 mmt -57.31 -43.12 83.0 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.2 m -64.5 -43.98 92.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.839 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.61 -38.87 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.36 0.6 . . . . 0.0 110.207 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.89 -37.87 86.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.41 -5.3 8.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -104.11 108.45 19.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.91 160.28 15.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.82 164.16 38.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.619 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 p -94.86 120.93 35.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.61 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -58.71 -36.59 74.5 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 124' ' ' MET . 80.1 mm-40 -73.38 -42.6 61.96 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.032 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.7 t -52.48 -67.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -45.28 -44.29 11.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.076 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -71.05 -32.33 69.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.087 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.3 ttt -53.3 -68.92 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 111.55 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 102' ' ' ALA . 17.9 mt -56.72 -40.69 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -50.69 -41.68 56.05 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.403 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.93 -45.19 36.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.807 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.69 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.17 -52.77 61.05 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.044 0.449 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 t0 -44.6 125.93 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.21 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.13 -29.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -92.96 -2.8 55.46 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.204 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.41 63.93 1.96 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 14.0 p-10 -126.14 -25.59 3.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.552 0.215 . . . . 0.0 111.091 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.13 13.19 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 100' ' ' ILE . 1.7 mm100 -136.72 136.66 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.477 -0.425 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.36 142.56 41.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.373 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.15 -155.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 6.8 m-85 -77.9 -53.07 7.89 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.03 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.7 mt-10 -57.59 -69.11 0.18 Allowed 'General case' 0 C--O 1.246 0.876 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.139 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 48.8 mt-10 -31.89 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.643 1.214 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.64 -54.1 4.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.025 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' GLU . 40.8 t -33.74 -60.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.426 0.454 . . . . 0.0 110.989 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.684 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 7.0 mp0 -40.0 -67.76 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.656 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.69 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 46.9 mmm -51.81 -45.74 64.0 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.449 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.455 ' SD ' ' CZ ' ' A' ' 89' ' ' PHE . 29.0 ttp -40.88 -67.25 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.578 0.228 . . . . 0.0 110.785 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -90.17 -60.33 1.96 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.756 0.312 . . . . 0.0 110.295 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -49.57 111.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 79' ' ' THR . 49.1 p30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 20.8 m -73.42 -48.96 29.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.0 -71.3 0.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.852 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 169.99 55.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -44.86 -33.65 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.74 -48.28 69.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.25 -47.02 62.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.73 -48.58 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 95.3 mtt-85 -58.51 -35.7 72.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.493 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.41 -65.78 0.88 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 111.475 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -39.06 -53.23 1.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.962 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' CG ' ' A' ' 141' ' ' PHE . 27.2 m-85 -64.93 -44.6 88.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.337 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.0 mmt180 -54.66 -44.01 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.76 -43.27 93.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -50.65 -52.28 41.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.616 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.2 t0 -49.85 94.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 92' ' ' PHE . 5.5 mptp? -54.88 -59.88 4.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.743 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 96' ' ' GLY . 86.1 m-20 -77.24 14.76 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.465 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 32.01 47.4 0.25 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.955 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.03 -7.74 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.296 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.91 -12.46 64.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 4.5 m-85 -134.46 148.27 50.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.5 mm -84.41 131.94 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.8 m -104.3 159.09 16.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.81 -36.49 75.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.68 77.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.235 0.541 . . . . 0.0 111.256 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 108' ' ' VAL . 94.0 mt-10 -66.04 -32.4 73.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 mt -65.21 -47.05 78.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.702 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 25.6 ptt180 -64.62 -44.9 89.06 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.875 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.58 -51.25 44.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 109' ' ' MET . 4.5 p -60.4 -49.09 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 108' ' ' VAL . 11.4 mmt -56.72 -42.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.8 m -64.15 -43.67 94.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.921 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -63.26 -39.16 93.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.44 -38.31 89.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.598 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.79 -3.81 4.62 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.47 105.9 15.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.918 0.39 . . . . 0.0 110.556 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -86.89 89.43 7.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.206 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.31 -172.58 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.1 p -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.108 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -55.26 -35.58 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.71 -40.67 97.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.95 -46.25 62.75 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.09 -69.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 28.5 t70 -44.22 -39.23 4.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.142 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -68.51 -38.91 81.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.133 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.9 mmt -54.24 -67.98 0.22 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.225 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.5 HG23 ' CG1' ' A' ' 136' ' ' VAL . 65.9 mt -54.25 -42.47 57.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 26.4 mmt180 -51.89 -44.91 63.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.72 2.79 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.06 36.16 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 125' ' ' ILE . 12.6 t70 -103.73 108.09 19.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.946 0.403 . . . . 0.0 111.38 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 132' ' ' GLY . 43.5 mm -72.59 172.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.882 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.671 ' N ' HG22 ' A' ' 130' ' ' ILE . 95.8 m-20 42.34 3.08 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.904 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 41.14 62.31 1.81 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -115.67 -21.92 9.44 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.99 5.41 41.07 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -135.82 142.76 44.89 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.3 m -136.19 138.92 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.46 -152.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.231 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -78.82 -57.52 3.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -52.54 -70.47 0.09 Allowed 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 139' ' ' GLU . 81.8 mt-10 -32.96 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.321 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.1 t80 -86.42 -52.34 5.66 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.659 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.7 t -35.76 -59.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.905 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -43.37 -15.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.343 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.535 ' N ' ' O ' ' A' ' 142' ' ' VAL . 74.1 mmm -101.2 -53.19 3.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 145' ' ' MET . 14.1 tmm? -70.89 -6.52 38.93 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.247 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 m -138.86 51.45 1.81 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.357 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.34 136.35 58.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.435 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.726 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 t -153.15 156.69 39.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.64 0.257 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' SER . 96.7 m-20 -59.84 -67.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' ASP . 79.7 p 35.63 -142.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.425 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -60.01 -14.03 14.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.405 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 8.7 tt0 -64.31 -51.77 61.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.365 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.83 -39.67 39.52 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.608 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.87 99.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -58.94 -33.04 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 97.6 mt-10 -74.55 -67.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.185 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -35.27 -46.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.539 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.03 -39.36 83.11 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.633 ' NH1' ' CZ ' ' A' ' 138' ' ' TYR . 39.6 mmt-85 -61.48 -46.56 89.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.979 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.25 -27.92 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.952 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -54.61 -50.52 67.86 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.135 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 38.3 t0 -56.82 86.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.503 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 96' ' ' GLY . 24.2 mttm -53.35 -53.0 57.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.025 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 t70 -72.96 17.78 0.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.486 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 26.16 42.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.289 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 23.0 p-10 -71.98 -8.74 56.24 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.057 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 91.79 17.57 47.79 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 94.5 m-85 -158.73 -172.12 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.6 118.03 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.492 ' CB ' HE22 ' A' ' 135' ' ' GLN . 35.6 t -101.24 159.99 14.78 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.75 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -66.92 -37.02 83.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.02 78.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.2 mt-10 -67.15 -35.59 80.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.26 -52.57 46.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.54 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -61.59 -44.55 96.81 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.481 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -67.52 -47.99 68.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.164 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.4 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.456 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 74.1 mmm -55.62 -46.11 77.43 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.9 m -63.42 -42.78 98.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.792 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -62.38 -40.46 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.387 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.43 -38.17 86.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.32 -7.84 16.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -84.92 115.39 22.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 110.752 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.11 141.17 56.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.214 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.74 163.32 40.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.563 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 p -104.05 124.59 49.31 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -56.89 -40.12 75.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.167 0.508 . . . . 0.0 110.574 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -59.77 -33.31 71.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.418 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 124' ' ' MET . 46.6 tp10 -74.6 -41.43 60.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 37.8 t -53.53 -65.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -47.18 -43.44 21.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -68.28 -34.97 77.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.658 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 120' ' ' GLU . 10.3 ttt -51.36 -66.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.563 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 102' ' ' ALA . 8.5 mt -57.44 -41.85 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -54.83 -43.34 72.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -83.17 -35.79 25.22 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.593 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -55.28 12.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.0 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 41.3 t0 -49.83 135.93 18.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 51.6 mt -104.94 -25.59 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 97.2 m-20 -87.65 -19.88 27.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.847 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.29 35.95 91.02 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 135' ' ' GLN . 27.8 p-10 -104.59 38.88 1.79 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.703 0.287 . . . . 0.0 110.92 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 52.48 0.84 0.04 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 133' ' ' ASP . 98.9 mm-40 -132.95 135.98 45.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.43 136.27 52.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.023 0.44 . . . . 0.0 110.081 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.32 -159.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.171 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.633 ' CZ ' ' NH1' ' A' ' 90' ' ' ARG . 3.1 m-85 -85.38 -55.73 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.454 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.629 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.6 mt-10 -55.99 -67.72 0.27 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.7 mt-10 -31.88 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.371 1.044 . . . . 0.0 109.925 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.629 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.5 t80 -90.1 -54.21 4.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.277 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' GLU . 72.9 t -37.94 -61.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.617 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 21.4 mp0 -41.01 -66.59 0.32 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.734 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 145' ' ' MET . 45.0 mmm -40.74 -46.67 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.15 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.533 ' O ' ' O ' ' A' ' 144' ' ' MET . 11.5 ttm -43.76 -111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.022 0.439 . . . . 0.0 111.795 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -131.91 22.55 4.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.417 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.77 83.63 2.78 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.301 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 10.2 t -141.72 -155.51 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -91.48 -47.72 7.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.641 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' ASP . 32.5 t 28.76 -83.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.737 0.648 . . . . 0.0 111.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.0 tt0 -49.3 -45.9 45.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 82.7 tt0 -66.98 -50.73 61.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.512 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -50.22 -44.99 53.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.219 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.71 -49.51 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 83' ' ' GLU . 83.0 mtm180 -56.49 -34.87 67.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.305 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 90' ' ' ARG . 81.0 mm-40 -74.43 -67.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.274 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.9 -50.18 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.965 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.85 -41.24 91.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' GLU . 74.3 mtt180 -57.46 -44.88 85.16 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.804 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.82 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.378 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.3 m-85 -49.42 -54.25 18.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.761 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 42.8 t0 -45.19 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 96' ' ' GLY . 1.3 tptp -55.55 -58.43 7.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.124 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 30.5 p30 -70.8 15.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.14 48.87 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.548 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 57.6 p30 -100.42 12.85 36.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.74 0.305 . . . . 0.0 111.503 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 69.81 36.79 74.98 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.718 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -157.57 167.18 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.445 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.0 mm -120.99 118.62 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -103.45 154.74 19.1 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.5 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -64.31 -37.83 88.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.027 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.44 -35.4 79.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.111 0.482 . . . . 0.0 111.63 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.0 mt-10 -68.1 -36.48 79.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.502 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.71 -47.28 81.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.763 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.99 -45.35 81.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.08 -53.0 61.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 104' ' ' GLU . 11.9 m -64.47 -42.46 95.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.946 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 108' ' ' VAL . 12.6 mmt -59.3 -48.25 82.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.0 m -65.33 -46.73 79.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -61.64 -39.24 90.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.849 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.04 -34.84 79.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.71 -16.84 13.78 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -70.05 124.68 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.729 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -74.94 134.57 41.51 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 121' ' ' VAL . 5.6 tp -150.97 155.79 39.81 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.434 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -96.73 122.24 39.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -52.66 -43.53 65.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.589 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.31 -29.61 67.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.358 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 124' ' ' MET . 84.4 tt0 -76.19 -45.56 32.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD23 ' A' ' 116' ' ' LEU . 40.6 t -51.33 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.296 0.569 . . . . 0.0 109.516 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -45.81 -45.59 14.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.011 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.28 -32.87 73.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.14 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 120' ' ' GLU . 31.4 tpp -52.5 -68.38 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.355 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 102' ' ' ALA . 22.8 mt -55.53 -42.04 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.919 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.31 -41.73 69.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.527 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -86.19 -33.6 20.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.613 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -68.68 -56.88 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.583 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -42.99 130.28 4.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.824 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.59 -34.07 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 86.9 m-20 -91.97 -3.78 55.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.033 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 46.1 63.45 2.94 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.61 -29.3 4.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.627 0.251 . . . . 0.0 111.053 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.56 -2.74 12.31 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -120.95 120.07 34.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -108.02 127.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -65.4 -153.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.736 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -85.72 -56.8 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.75 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 141' ' ' PHE . 4.9 pt-20 -60.89 -64.32 1.0 Allowed 'General case' 0 C--O 1.241 0.631 0 O-C-N 123.221 0.325 . . . . 0.0 111.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.578 ' H ' ' CG ' ' A' ' 139' ' ' GLU . 94.1 mt-10 -32.83 -29.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.999 0.812 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -88.52 -54.86 3.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.76 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 139' ' ' GLU . 41.6 t -34.21 -59.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.785 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 18.9 mp0 -41.32 -69.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.513 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 4.1 mmt -43.58 -46.23 7.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.9 ttp -68.9 149.43 48.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.29 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.99 -0.87 3.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.453 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.86 136.3 53.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.157 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.249 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 79' ' ' THR . 66.3 m -67.4 -2.56 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.757 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 34.5 p-10 -118.93 -8.21 10.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 83' ' ' GLU . 26.5 t -96.55 114.49 26.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -45.32 -15.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' SER . 81.9 tt0 -62.58 -52.04 64.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -47.53 -49.67 25.6 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.323 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.32 -49.02 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 99.8 mtt180 -60.0 -38.87 83.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.58 -64.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 111.409 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.92 -54.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.768 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.88 -43.29 93.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.171 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.9 mmt180 -56.05 -44.3 78.73 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.747 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.15 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.08 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -52.91 -52.77 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.487 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 36.5 t0 -51.26 88.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' N ' ' A' ' 108' ' ' VAL . 34.1 mttt -55.4 -59.41 4.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.01 0.434 . . . . 0.0 110.365 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 97' ' ' ASN . 98.0 m-20 -71.91 18.15 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.323 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 25.67 44.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.854 0.721 . . . . 0.0 112.079 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.717 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -75.27 -3.83 35.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.209 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.78 -2.51 69.82 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.717 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 67.6 m-85 -139.98 -168.62 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -129.87 127.16 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.656 ' CB ' HE22 ' A' ' 135' ' ' GLN . 22.5 t -104.07 166.15 10.59 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 124.152 0.908 . . . . 0.0 110.669 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -73.21 -37.75 66.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.04 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.24 77.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 88.6 mt-10 -65.54 -33.18 75.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.269 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 109' ' ' MET . 41.0 mt -63.59 -51.87 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.837 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 12.4 ptp180 -60.79 -48.63 80.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.926 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 73.7 m-70 -64.82 -53.21 50.47 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.946 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.634 ' N ' ' NZ ' ' A' ' 94' ' ' LYS . 4.1 p -61.3 -49.13 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.616 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.7 mmt -55.7 -46.58 77.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 110.14 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.9 m -65.74 -44.41 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.985 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -61.35 -39.38 90.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.82 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mt -62.19 -38.64 89.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.375 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.28 -6.39 3.64 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -108.57 100.94 10.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.761 0.315 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -81.34 89.23 6.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.69 -172.61 1.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -108.58 129.25 55.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -58.25 -40.56 82.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.37 -39.58 79.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -73.05 -42.88 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.975 178.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 102' ' ' ALA . 31.1 t -51.93 -67.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.477 0.656 . . . . 0.0 109.551 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 42.4 t0 -46.84 -42.55 17.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.496 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.48 -40.34 81.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.6 mmt -51.54 -69.77 0.1 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 111.754 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.445 HD12 ' CA ' ' A' ' 102' ' ' ALA . 23.5 mt -53.02 -42.5 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.066 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 19.3 mmt85 -51.65 -41.34 61.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.765 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.93 -45.7 23.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.568 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -63.08 -52.83 61.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 110.731 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.3 t0 -41.7 126.42 3.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.9 -30.0 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.71 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 69.6 m-20 -91.49 -5.34 54.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.556 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 43.87 63.15 2.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -124.24 -24.99 4.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.516 0.198 . . . . 0.0 110.926 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 120.29 -0.95 12.89 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.656 HE22 ' CB ' ' A' ' 101' ' ' SER . 93.7 mm-40 -136.63 139.36 42.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 122.426 -0.456 . . . . 0.0 109.961 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -132.52 140.95 46.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -65.77 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.467 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.6 m-85 -79.09 -53.15 7.29 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.974 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.6 mt-10 -57.76 -69.79 0.16 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 119.788 -0.149 . . . . 0.0 110.766 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' GLU . 95.5 mt-10 -31.39 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.542 1.151 . . . . 0.0 109.342 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -89.23 -55.48 3.65 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.906 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' GLU . 47.0 t -31.81 -60.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 123.491 0.495 . . . . 0.0 110.548 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 142' ' ' VAL . 98.3 mm-40 -39.6 -68.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.547 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 3.5 mmt -42.93 -48.05 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.64 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 33.6 ttp -59.76 135.9 57.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.796 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.4 p -78.31 47.29 0.68 Allowed 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.44 96.29 7.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.914 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.716 179.718 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -122.27 53.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -50.69 -49.1 58.24 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 70.16 -49.09 0.64 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.132 0.491 . . . . 0.0 110.835 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -42.64 -42.41 3.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.502 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' HH21 ' A' ' 86' ' ' ARG . 96.7 mt-10 -65.34 -50.91 63.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.823 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -47.85 -51.19 23.83 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.233 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.59 -50.84 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.444 HH21 ' HG3' ' A' ' 83' ' ' GLU . 76.3 mtm180 -57.78 -37.64 74.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.11 -68.17 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.857 0.36 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -54.77 0.91 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.03 -39.77 93.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -58.02 -45.78 86.36 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.17 -42.48 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.881 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -51.2 -54.31 26.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.718 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.1 t0 -51.29 86.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.0 mtpt -52.72 -57.11 11.19 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 96' ' ' GLY . 98.1 m-20 -66.29 16.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.424 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 27.28 45.51 0.04 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.707 0.629 . . . . 0.0 111.963 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 45.4 p-10 -94.0 10.05 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.142 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.11 35.07 77.19 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.1 m-85 -159.89 170.79 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' CE2' ' A' ' 141' ' ' PHE . 48.0 mm -120.12 114.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 t -100.23 159.73 14.89 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.313 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.21 -37.98 89.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.021 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -62.3 -36.09 81.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.659 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 108' ' ' VAL . 53.8 mt-10 -66.38 -37.6 85.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.055 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 mt -65.07 -55.75 17.04 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 111.541 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 50.0 ptt85 -56.57 -48.72 76.75 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.927 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 94' ' ' LYS . 45.6 t-80 -65.44 -55.37 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.507 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 109' ' ' MET . 3.4 p -60.09 -48.85 86.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.754 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 108' ' ' VAL . 5.2 mmt -55.66 -47.23 77.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.9 m -63.05 -43.63 98.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 109.812 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -62.92 -40.08 96.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.033 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.46 -37.66 81.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.11 -6.41 4.35 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -98.52 97.14 8.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.943 0.401 . . . . 0.0 110.922 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -74.8 80.5 2.09 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.93 -172.14 1.87 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.279 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.1 p -112.33 130.08 56.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 110.206 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -57.45 -38.31 74.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.703 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.14 -38.29 85.87 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.511 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' MET . 97.4 mt-10 -73.73 -44.07 57.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.873 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -54.55 -64.6 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -45.11 -43.3 9.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -70.75 -34.99 72.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 120' ' ' GLU . 30.4 ttm -49.72 -68.65 0.16 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 102' ' ' ALA . 21.3 mt -53.39 -44.84 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.108 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -52.17 -42.23 63.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.578 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.88 -43.52 19.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.59 -55.0 27.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 42.7 t0 -44.85 132.62 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.588 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 48.8 mt -93.25 -28.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.02 0.438 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 23.3 t0 -96.33 -4.64 41.69 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.72 64.9 1.95 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.0 p-10 -125.03 -31.0 3.16 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . 121.52 -2.33 11.22 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 134' ' ' GLY . 72.5 mm-40 -120.82 115.22 22.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 125' ' ' ILE . 21.4 t -108.86 128.9 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -68.25 -152.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.703 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 142' ' ' VAL . 19.2 m-85 -85.37 -54.33 4.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.275 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 141' ' ' PHE . 56.7 mp0 -62.22 -67.67 0.39 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.234 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.5 mt-10 -32.17 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.235 0.96 . . . . 0.0 109.746 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.602 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -89.45 -56.51 3.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.791 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.3 t -31.73 -59.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.821 0.344 . . . . 0.0 110.79 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -42.11 -69.83 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 tpp -43.89 -50.26 8.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.426 ' HG2' ' H ' ' A' ' 147' ' ' ALA . 59.8 ttp -59.44 142.42 52.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.1 p -109.09 -6.5 15.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.707 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 145' ' ' MET . . . -64.3 151.14 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.196 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.501 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -99.76 -60.66 1.49 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.716 0.293 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -76.72 -13.25 60.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -59.29 -55.7 31.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.381 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -53.83 -36.11 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.0 -51.29 40.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -50.18 -38.33 39.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.09 -46.83 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.25 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -59.19 -36.31 75.13 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.176 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 88' ' ' ALA . 98.1 mt-10 -73.52 -70.18 0.39 Allowed 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.573 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.36 -44.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.39 -55.32 16.4 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' C ' ' CD ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.42 -41.52 69.44 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.915 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.15 -19.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.039 0.447 . . . . 0.0 110.217 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 108' ' ' VAL . 2.9 t80 -55.03 -47.85 74.2 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.429 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' GLY . 49.7 t0 -50.0 108.8 0.23 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.478 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -42.55 -43.6 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.637 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.46 -23.45 53.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 61.98 56.31 23.17 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.583 ' C ' HD22 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -106.73 7.14 30.26 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.447 0.624 . . . . 0.0 111.733 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.558 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 83.81 22.71 54.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.29 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.543 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.9 m-85 -148.58 147.72 29.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' CG2' HD21 ' A' ' 105' ' ' LEU . 32.9 mm -108.54 115.6 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.864 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 t -108.23 159.4 16.65 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.74 90.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.45 74.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 111.021 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' HG12 ' A' ' 108' ' ' VAL . 82.5 mt-10 -68.44 -39.26 81.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.463 HD21 ' CG2' ' A' ' 100' ' ' ILE . 44.6 mt -63.99 -49.94 70.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.284 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 37.6 ptt180 -63.31 -43.31 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.878 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 12.0 m80 -66.12 -54.46 25.32 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.499 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 109' ' ' MET . 4.8 p -62.88 -45.99 97.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.078 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.482 ' N ' HG13 ' A' ' 108' ' ' VAL . 4.8 mmt -60.11 -49.15 78.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.667 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.2 m -62.58 -42.98 99.89 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.9 -37.79 88.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.367 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.61 -36.28 80.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.431 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.28 -2.24 3.49 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -113.96 104.72 12.44 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.52 93.67 7.87 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mp -76.2 -171.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.896 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.05 127.13 53.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.86 -36.76 67.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.346 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.8 -35.63 80.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.5 tt0 -72.91 -45.46 58.05 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.927 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' MET . 48.8 t -57.56 -62.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -44.49 -42.04 6.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.974 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -74.26 -30.71 62.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.002 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 121' ' ' VAL . 30.4 ttm -51.83 -63.35 1.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.772 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 ' CG2' ' A' ' 136' ' ' VAL . 34.0 mt -60.45 -45.38 96.91 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-O 120.824 0.345 . . . . 0.0 110.344 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -44.23 -37.43 3.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.497 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.33 -33.21 25.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.838 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -93.7 33.42 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.863 0.363 . . . . 0.0 110.537 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.3 t70 -117.77 115.16 24.44 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.206 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.76 -35.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.017 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 63.7 t0 -85.34 -22.67 28.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.919 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 66.01 43.46 93.46 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -112.77 -30.52 7.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.475 0.178 . . . . 0.0 111.102 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 116.35 9.12 11.98 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -124.89 124.41 42.0 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 125' ' ' ILE . 25.7 t -112.16 129.02 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.089 0.471 . . . . 0.0 110.626 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.54 -154.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.553 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -81.21 -59.35 2.68 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.384 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.0 mt-10 -57.32 -66.36 0.47 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.854 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.6 mt-10 -33.23 -32.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.335 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -82.71 -53.78 5.65 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.437 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 139' ' ' GLU . 54.6 t -38.06 -61.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.995 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -43.55 -16.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 15.2 ttm -98.13 -51.4 4.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.29 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.9 ttp -54.18 134.1 44.44 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 110.914 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.3 m -99.9 -30.16 12.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.79 138.9 17.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.76 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.0 p -93.78 82.32 4.29 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.312 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -90.05 7.44 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.344 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 83' ' ' GLU . 23.0 t -93.77 51.72 1.59 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.396 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -44.75 -19.75 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.373 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 81' ' ' SER . 37.7 mp0 -62.93 -47.81 81.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.084 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -50.12 -47.65 53.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.176 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.88 -49.49 69.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 91.3 mtm-85 -60.34 -35.8 76.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.23 -64.2 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.357 0.598 . . . . 0.0 111.155 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -41.29 -54.72 2.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.752 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -65.61 -41.57 92.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 16.6 mmt180 -55.66 -42.99 75.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.694 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.04 -42.18 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.874 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -51.24 -51.83 50.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.563 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 41.5 t0 -48.76 93.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.2 tptm -56.14 -58.47 7.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.503 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 80.9 m-20 -75.08 13.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.27 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 33.08 47.29 0.34 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.829 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.529 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 54.6 p30 -87.65 6.38 34.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.862 -0.199 . . . . 0.0 111.105 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 76.59 25.79 64.53 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.742 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 80.4 m-85 -154.21 171.99 18.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.5 mm -121.13 125.48 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.641 ' CB ' HE22 ' A' ' 135' ' ' GLN . 20.9 t -106.97 170.69 7.79 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.822 0.702 . . . . 0.0 110.189 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -77.89 -35.32 50.92 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.17 76.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.441 . . . . 0.0 111.555 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.6 mt-10 -66.34 -33.17 75.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.92 -49.93 66.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.591 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -62.94 -44.65 95.5 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.023 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -68.83 -51.06 44.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -62.33 -48.22 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.015 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.463 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 6.9 mmt -60.15 -45.1 94.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.2 m -62.72 -43.58 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 109.504 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.2 -37.11 86.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.177 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.8 -34.86 78.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.59 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.03 -4.06 4.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -115.73 110.35 18.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.709 0.29 . . . . 0.0 110.39 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.83 95.33 10.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.994 0.426 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 116' ' ' LEU . 7.0 mp -76.68 -172.51 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 p -99.72 124.76 45.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.824 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -56.8 -40.92 76.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -63.52 -33.71 76.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.538 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.5 tt0 -75.98 -42.49 48.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.25 -61.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -50.57 -43.43 56.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -69.21 -35.07 75.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.376 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 120' ' ' GLU . 29.4 tpp -51.14 -67.08 0.28 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.638 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD12 ' CA ' ' A' ' 102' ' ' ALA . 12.5 mt -57.43 -40.0 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.63 0.253 . . . . 0.0 110.979 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -51.01 -40.52 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.15 -37.41 23.75 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.967 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -73.42 -53.57 10.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.485 0.66 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 13.1 t70 -37.16 124.81 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.412 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 131' ' ' ASP . 44.2 mm -74.8 -179.14 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.779 ' H ' HG22 ' A' ' 130' ' ' ILE . 31.3 t0 37.54 5.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 130' ' ' ILE . . . 46.4 60.05 4.92 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 15.1 p-10 -110.46 -26.4 9.53 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.696 -0.297 . . . . 0.0 111.509 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 107.37 1.49 35.31 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.641 HE22 ' CB ' ' A' ' 101' ' ' SER . 98.4 mm-40 -132.18 139.28 48.31 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.67 138.8 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.164 0.507 . . . . 0.0 111.559 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.65 -153.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.709 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 90' ' ' ARG . 4.1 m-85 -78.19 -54.74 5.9 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 141' ' ' PHE . 79.5 mm-40 -55.69 -68.22 0.22 Allowed 'General case' 0 C--O 1.246 0.884 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.1 mt-10 -33.12 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.5 t80 -90.03 -52.85 4.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.739 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 139' ' ' GLU . 48.0 t -33.62 -60.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.786 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 142' ' ' VAL . 96.9 mt-30 -40.02 -67.58 0.22 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.694 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 25.6 mmt -44.79 -47.22 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 55.2 ttp -60.5 139.21 57.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.339 . . . . 0.0 110.533 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.3 p -64.37 -47.19 80.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.03 53.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.43 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 79' ' ' THR . 0.6 OUTLIER -149.65 26.74 0.83 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.518 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -79.98 -3.38 48.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 53.6 p -79.66 -58.1 3.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' N ' ' OG ' ' A' ' 81' ' ' SER . 82.9 tt0 -49.39 -20.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.069 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.56 ' CD ' HH21 ' A' ' 86' ' ' ARG . 44.8 tp10 -63.49 -53.5 51.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.629 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -47.33 -45.83 24.84 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.64 -49.23 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CD ' ' A' ' 83' ' ' GLU . 31.0 mtm180 -58.63 -36.76 74.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.369 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -75.5 -67.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.01 -52.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.934 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -65.56 -44.26 87.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.191 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -53.28 -45.01 68.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.481 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.24 -42.88 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.358 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.6 m-85 -53.04 -53.51 49.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLY . 57.7 t0 -52.16 90.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -41.78 -49.89 4.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 110.088 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.32 -22.93 64.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.121 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 52.38 57.38 13.73 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.666 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.34 14.23 19.2 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.842 0.321 . . . . 0.0 111.837 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 82.76 32.28 27.46 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 94.1 m-85 -159.32 163.07 36.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.3 mm -129.27 126.15 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 p -106.98 163.4 13.0 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 124.1 0.875 . . . . 0.0 110.574 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -66.97 -39.07 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.987 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.71 70.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.814 0.34 . . . . 0.0 111.55 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -68.92 -34.66 75.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.38 -52.81 56.4 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 118' ' ' ASP . 38.3 ptt180 -61.33 -45.61 93.7 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -64.27 -52.27 59.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 109' ' ' MET . 3.7 p -63.24 -46.43 95.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.677 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.482 ' HB3' HD23 ' A' ' 116' ' ' LEU . 17.7 mmt -58.32 -48.96 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -62.86 -42.56 99.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -62.89 -39.5 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.23 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.89 -36.42 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.97 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.52 -0.35 2.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.34 114.34 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -83.29 96.08 8.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.782 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' MET . 2.1 mm? -71.88 179.64 3.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.8 p -108.05 127.19 53.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.06 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 106' ' ' ARG . 31.4 t0 -55.54 -37.73 68.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.386 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.51 -38.13 89.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 124' ' ' MET . 81.8 tt0 -75.39 -49.2 19.73 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' HB1' ' A' ' 102' ' ' ALA . 12.5 t -54.9 -65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -45.56 -44.23 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.47 -32.75 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.039 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 120' ' ' GLU . 11.6 ttt -52.02 -67.58 0.24 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 102' ' ' ALA . 25.6 mt -57.05 -45.39 84.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.056 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -43.87 -37.4 2.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.06 -55.01 6.0 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.86 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 140' ' ' GLU . . . -58.67 -50.2 74.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.967 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 t70 -39.29 121.92 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.132 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mt -103.97 -26.1 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -89.4 -26.17 21.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.832 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 78.23 25.42 61.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.86 32.46 2.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 111.266 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.68 15.35 2.08 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -148.12 155.62 41.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.956 0.407 . . . . 0.0 110.507 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.2 m -138.76 147.75 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.7 -153.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.194 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.1 m-85 -78.72 -54.34 6.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.2 mt-10 -59.57 -67.31 0.39 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 121.184 -0.207 . . . . 0.0 111.054 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.525 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 92.0 mt-10 -31.19 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.367 1.042 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -83.6 -58.34 2.85 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.683 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 144' ' ' MET . 69.0 t -35.25 -61.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -41.94 -14.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.13 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 145' ' ' MET . 70.9 mmm -97.16 -49.4 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.427 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.626 ' O ' ' O ' ' A' ' 144' ' ' MET . 27.5 ttm -45.87 -125.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.608 0.718 . . . . 0.0 111.428 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.3 p -138.16 34.63 2.33 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.481 -0.762 . . . . 0.0 110.428 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.57 93.57 8.6 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.099 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.056 -179.576 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p 39.8 76.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.614 0.245 . . . . 0.0 110.886 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.42 -34.25 77.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' GLU . 9.6 t -63.95 -57.02 11.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.126 0.488 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -39.42 -27.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.538 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' SER . 74.5 tt0 -65.23 -50.06 67.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.747 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -47.71 -52.14 19.44 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 85' ' ' ILE . 61.8 mt -52.53 -50.52 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -57.2 -38.98 74.49 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -76.77 -66.8 0.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 0.0 111.423 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.28 -56.26 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.113 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -64.55 -39.32 93.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -57.7 -46.24 84.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.666 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.12 -43.84 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.9 m-85 -48.4 -56.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.579 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 44.8 t0 -50.22 87.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.02 -55.66 9.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.19 -179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.04 -0.6 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.021 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 37.68 52.48 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.774 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 16.7 p-10 -107.3 14.19 26.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.099 0.449 . . . . 0.0 111.59 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 72.29 38.79 58.5 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.5 m-85 -157.21 163.33 38.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 141' ' ' PHE . 51.3 mm -121.76 119.32 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.1 m -104.08 159.95 15.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.444 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -63.59 -38.81 92.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.888 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.87 71.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.647 0.26 . . . . 0.0 111.394 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 108' ' ' VAL . 78.6 mt-10 -67.63 -35.44 78.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.47 -58.04 6.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.412 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -46.99 83.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.492 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.4 t -64.47 -48.73 83.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.437 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.9 mmm -59.35 -50.89 72.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.9 m -61.64 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -64.18 -37.56 87.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.2 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.73 -37.75 82.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.587 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -3.9 7.59 Favored Glycine 0 N--CA 1.468 0.806 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.34 -172.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.671 0.272 . . . . 0.0 111.085 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -143.49 52.12 1.35 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 111.238 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.779 HD22 ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -71.87 175.65 5.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.915 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.595 ' N ' HD22 ' A' ' 116' ' ' LEU . 39.1 p -115.94 131.77 56.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.928 0.394 . . . . 0.0 110.583 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -53.04 -37.37 61.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.966 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.62 -33.75 74.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' MET . 91.6 mt-10 -75.01 -46.64 33.76 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.065 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 HD23 ' A' ' 116' ' ' LEU . 4.5 t -50.83 -68.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 121' ' ' VAL . 41.7 t0 -45.43 -44.01 11.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -69.79 -37.01 76.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.978 0.418 . . . . 0.0 111.215 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . 2.2 ttp -50.15 -69.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.28 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 136' ' ' VAL . 27.9 mt -52.44 -45.81 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.876 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -51.78 -41.01 61.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.601 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -83.07 -41.85 18.13 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.43 -55.79 16.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 37.2 t0 -40.36 130.78 2.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.99 -33.92 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 96.3 m-20 -92.75 -3.76 54.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.924 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 44.33 64.37 2.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 14.0 p-10 -125.12 -29.08 3.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.7 -3.16 13.47 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -119.26 116.63 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.457 ' CG2' HG23 ' A' ' 125' ' ' ILE . 23.1 t -108.68 127.21 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.2 t30 -65.83 -152.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.601 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 m-85 -86.51 -55.04 4.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.444 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 141' ' ' PHE . 57.1 mp0 -63.0 -65.97 0.61 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.079 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 139' ' ' GLU . 93.5 mt-10 -32.51 -28.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.421 1.075 . . . . 0.0 109.552 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.7 t80 -89.11 -56.82 3.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.86 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 138' ' ' TYR . 49.9 t -33.04 -60.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.747 0.308 . . . . 0.0 110.841 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -43.33 -70.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -42.23 -50.19 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.01 148.87 46.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.57 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 146' ' ' THR . 25.2 m -135.93 -7.9 2.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.2 131.04 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.156 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 117.684 -1.151 . . . . 0.0 109.318 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 66.1 t0 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.7 p -126.18 11.59 7.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.718 0.294 . . . . 0.0 110.681 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' O ' ' OG ' ' A' ' 81' ' ' SER . 99.1 m-20 -57.37 -46.18 83.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 72.1 m -170.1 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.292 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -42.28 -37.71 1.59 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.444 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.19 -50.39 68.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.622 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -46.97 -49.42 20.78 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.516 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.12 -45.75 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -60.53 -39.04 86.42 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.013 -0.43 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.19 -66.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.81 -55.39 1.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.09 -42.26 96.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -56.02 -44.78 79.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.484 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.59 -43.52 98.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.319 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.8 m-85 -48.2 -55.43 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.519 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 43.5 t0 -55.48 82.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -48.52 -53.47 17.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLY . 43.3 t0 -64.68 4.69 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 32.73 49.48 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 30.6 p30 -102.7 11.7 37.32 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.785 0.292 . . . . 0.0 111.618 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 70.71 38.73 66.93 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 63.9 m-85 -159.5 166.58 30.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 141' ' ' PHE . 49.1 mm -122.23 115.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -99.3 160.02 14.57 Favored 'General case' 0 C--N 1.345 0.392 0 O-C-N 123.594 0.559 . . . . 0.0 109.654 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -64.62 -37.54 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.932 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -59.74 -36.36 76.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 108' ' ' VAL . 60.8 mt-10 -67.63 -34.66 77.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.47 -56.18 13.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.387 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 49.1 ptt85 -57.89 -46.88 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.793 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.536 ' C ' ' HD1' ' A' ' 107' ' ' HIS . 1.8 t-80 -63.62 -45.55 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.727 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.3 t -63.23 -48.75 86.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.569 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.2 mmt -58.84 -47.71 83.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.776 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.2 m -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.91 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -63.4 -38.61 91.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 110.525 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 112' ' ' LEU . 19.5 mt -60.08 -37.62 80.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.959 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.75 2.62 2.79 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 114' ' ' GLU . 55.1 mp0 -123.57 117.65 25.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.4 95.61 10.36 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.179 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.27 -171.37 2.37 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -105.31 123.31 47.63 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.126 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.76 -35.37 70.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.372 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.21 -36.59 82.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.479 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 124' ' ' MET . 92.7 mt-10 -74.65 -44.84 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.122 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.03 -64.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -46.17 -43.32 15.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.905 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 123' ' ' GLU . 1.4 tm-20 -71.51 -33.91 69.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.853 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 120' ' ' GLU . 6.7 tpt -50.34 -67.44 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.979 0.418 . . . . 0.0 111.389 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.601 HG23 HG23 ' A' ' 136' ' ' VAL . 23.4 mt -55.31 -43.32 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.886 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -53.05 -41.17 64.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.345 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.88 -43.03 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.789 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.44 -53.72 50.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 39.0 t0 -43.71 131.04 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.519 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.19 -33.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 91.9 m-20 -91.93 -5.47 53.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.762 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 45.64 62.83 3.07 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 10.2 p-10 -119.8 -29.16 5.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.488 0.185 . . . . 0.0 110.809 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.27 -5.5 10.2 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.75 121.89 38.29 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 HG23 ' A' ' 125' ' ' ILE . 19.1 t -107.28 128.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.47 0.653 . . . . 0.0 110.343 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.01 -154.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.071 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -87.94 -55.12 3.9 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.377 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 141' ' ' PHE . 70.7 mm-40 -60.22 -66.26 0.55 Allowed 'General case' 0 C--O 1.244 0.772 0 C-N-CA 121.359 -0.137 . . . . 0.0 110.64 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 139' ' ' GLU . 90.7 mt-10 -32.71 -27.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.457 1.098 . . . . 0.0 109.256 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' N ' ' O ' ' A' ' 139' ' ' GLU . 2.1 t80 -89.88 -55.2 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.094 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' GLU . 39.2 t -32.47 -58.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.467 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 146' ' ' THR . 99.5 mm-40 -40.99 -67.11 0.27 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.252 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.3 mmt -44.28 -48.89 9.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.207 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.528 ' O ' ' SD ' ' A' ' 145' ' ' MET . 13.8 tmm? -73.47 -8.44 55.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 143' ' ' GLN . 2.7 m -137.58 44.5 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.869 0.366 . . . . 0.0 110.74 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.09 138.16 31.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.168 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.827 -179.559 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 p -80.22 24.68 0.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 110.456 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 81' ' ' SER . 36.2 t70 -82.97 5.8 20.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.644 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 83' ' ' GLU . 3.6 p 86.07 10.05 0.25 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.193 0.52 . . . . 0.0 110.741 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -56.58 -2.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.22 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 81' ' ' SER . 70.8 mm-40 -61.55 -52.02 66.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.896 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -50.01 -52.83 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.262 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -51.1 -50.18 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.499 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.44 -33.55 65.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.815 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -78.12 -68.92 0.59 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.698 0.285 . . . . 0.0 111.257 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.79 -53.44 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.325 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -65.42 -41.61 93.38 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.245 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -57.24 -44.56 83.94 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.866 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.4 t -64.04 -43.88 97.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.262 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' LYS . 2.7 m-85 -48.9 -52.98 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.062 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 47.7 t0 -52.32 89.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 92' ' ' PHE . 1.5 mptm? -46.71 -54.56 9.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -72.52 -27.37 62.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.61 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 75.68 48.66 10.0 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.894 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.506 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 14.0 m120 -80.79 3.25 23.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.154 0.477 . . . . 0.0 111.348 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.43 -3.89 83.92 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -135.69 -168.75 2.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 141' ' ' PHE . 44.3 mm -128.62 125.85 64.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.5 t -100.58 167.11 10.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.613 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -72.86 -36.31 67.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.08 74.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.13 0.49 . . . . 0.0 111.535 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 108' ' ' VAL . 81.7 mt-10 -67.68 -33.97 75.99 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.09 -0.381 . . . . 0.0 111.25 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.07 -55.19 23.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.825 0.345 . . . . 0.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 37.8 ptt180 -58.85 -47.5 84.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.736 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 106' ' ' ARG . 25.9 t60 -65.55 -54.81 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.2 p -59.51 -49.54 83.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.869 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.507 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 4.1 mmt -57.51 -47.59 81.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.6 m -63.03 -43.8 97.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.14 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.64 -38.09 89.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.13 -33.91 75.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.94 -5.86 4.03 Favored Glycine 0 N--CA 1.465 0.576 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -115.52 108.04 15.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 110.785 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.71 96.32 10.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.147 0.498 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.5 mp -77.86 -169.13 1.42 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.485 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 p -104.26 127.61 51.92 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 110.24 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.35 -42.53 82.16 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.58 -35.52 78.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' MET . 82.8 tt0 -75.23 -42.98 54.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -57.45 -61.86 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -46.95 -44.45 20.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -72.85 -32.25 65.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.8 tpp -50.41 -70.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 102' ' ' ALA . 15.9 mt -52.63 -43.8 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.8 mmt-85 -47.47 -37.49 11.92 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.535 0.522 . . . . 0.0 111.69 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -82.81 -35.64 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.01 0.434 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -70.85 -55.55 8.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 110.718 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 10.0 t0 -41.86 124.97 2.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.259 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.6 mm -89.24 -34.14 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.49 -7.14 42.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.175 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.617 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 60.02 39.85 96.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 135' ' ' GLN . 19.2 p-10 -100.48 37.18 1.73 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.24 3.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.544 ' H ' ' C ' ' A' ' 133' ' ' ASP . 69.7 mt-30 -145.26 152.65 40.27 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.493 -0.416 . . . . 0.0 110.119 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.97 146.67 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.043 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.755 HD21 ' H ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.55 -154.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.664 0.602 . . . . 0.0 110.936 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.8 m-85 -80.63 -53.03 6.91 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.808 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 141' ' ' PHE . 97.3 mt-10 -57.31 -72.23 0.09 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.933 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.755 ' H ' HD21 ' A' ' 137' ' ' ASN . 91.9 mt-10 -30.68 -26.1 0.0 OUTLIER 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.113 0.883 . . . . 0.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.696 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.4 t80 -91.38 -57.64 2.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.951 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 54.5 t -31.89 -60.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.676 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -38.97 -68.18 0.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.519 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.556 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 42.0 mmm -49.89 -49.73 48.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.828 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.2 ttp -43.38 126.96 4.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.03 0.443 . . . . 0.0 111.124 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 p -135.24 54.82 1.91 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.723 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.61 159.9 23.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.503 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.1 m -130.17 121.18 25.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' A' ' 81' ' ' SER . 80.1 m-20 -73.86 -47.54 37.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 24.9 p 59.49 81.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.083 0.468 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.97 -15.91 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.447 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 81' ' ' SER . 58.3 mp0 -64.42 -51.98 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.876 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -51.1 -49.53 60.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.141 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -55.61 -49.44 73.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' CE2' ' A' ' 138' ' ' TYR . 17.7 mmm180 -56.27 -34.47 66.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 90' ' ' ARG . 94.5 mt-10 -74.64 -68.52 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.937 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -34.37 -50.72 0.43 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -64.02 -43.81 94.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' GLU . 17.1 mmt85 -54.6 -44.74 73.33 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.773 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -42.69 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.837 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m-85 -57.25 -52.86 63.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.914 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 49.1 t0 -51.93 86.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.0 tptp -43.51 -52.71 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.246 0.546 . . . . 0.0 110.119 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.55 -23.16 65.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 59.11 55.43 30.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.91 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 93' ' ' ASP . 31.8 p-10 -115.57 14.04 16.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.102 0.451 . . . . 0.0 111.975 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 77.81 38.39 27.43 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.513 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 86.7 m-85 -158.32 161.28 37.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 141' ' ' PHE . 46.0 mm -126.27 118.25 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.5 m -99.48 161.41 13.63 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 124.258 0.974 . . . . 0.0 110.197 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.529 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -68.35 -37.36 80.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.31 76.35 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.81 -32.91 74.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.324 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.73 -52.78 58.96 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.206 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 12.8 ptp180 -61.59 -46.47 89.73 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.726 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -51.6 62.27 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.643 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.4 p -62.68 -47.85 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.406 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.469 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.5 mmt -57.11 -47.74 80.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 m -64.54 -43.93 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.869 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.0 -39.04 88.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.266 0.555 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.96 -37.94 84.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.884 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.58 0.29 3.3 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -119.77 112.98 19.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.723 0.296 . . . . 0.0 110.486 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -87.55 95.2 9.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.36 -172.16 2.02 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.122 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.4 ' OG1' ' CD ' ' A' ' 120' ' ' GLU . 4.6 p -103.51 123.97 47.89 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.065 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.52 -40.46 87.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.575 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.88 -38.5 78.98 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.3 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -73.2 -40.88 64.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.529 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.2 t -53.81 -65.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -47.18 -43.2 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.058 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -69.58 -37.66 77.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.88 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 120' ' ' GLU . 28.5 ttm -50.59 -67.35 0.26 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.068 0.461 . . . . 0.0 111.54 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 102' ' ' ALA . 22.5 mt -56.86 -39.0 61.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.159 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -54.05 -42.15 68.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.97 -35.73 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -66.96 -55.57 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.706 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 20.0 t0 -43.14 133.23 3.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.411 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mm -91.4 -30.39 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 59.6 t0 -105.01 -7.29 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 59.65 37.94 93.04 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 135' ' ' GLN . 17.5 p-10 -90.54 35.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 0.0 111.122 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 59.26 0.35 0.76 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 133' ' ' ASP . 44.6 mt-30 -148.18 157.52 43.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.509 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -133.8 146.37 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.137 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -67.81 -155.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 68.1 m-85 -79.6 -52.52 7.89 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.996 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 141' ' ' PHE . 96.3 mt-10 -59.24 -67.49 0.37 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.414 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 139' ' ' GLU . 79.0 mt-10 -31.39 -30.22 0.01 OUTLIER 'General case' 0 C--N 1.353 0.719 0 O-C-N 124.586 1.178 . . . . 0.0 109.449 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -88.27 -54.79 4.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.763 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 139' ' ' GLU . 43.4 t -33.24 -62.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.389 0.431 . . . . 0.0 110.597 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -41.47 -68.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.715 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.438 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 23.6 mmt -43.2 -49.09 6.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.397 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.2 ttm -42.46 -68.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.979 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.7 m -115.28 49.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 110.672 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.8 141.7 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.218 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.015 -179.492 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 81' ' ' SER . 89.9 m -132.76 124.82 28.81 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.0 -6.96 53.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.692 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' THR . 46.7 t 47.01 82.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -45.64 -32.7 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.369 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -68.28 -46.73 69.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.791 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -51.48 -47.27 63.24 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.34 -46.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 90' ' ' ARG . 22.7 mmt85 -60.23 -35.0 74.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -76.33 -67.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.912 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -38.2 -51.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.55 -42.04 92.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 22.2 mmt180 -59.06 -43.5 91.73 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.103 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.51 -41.56 91.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.083 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.76 -50.69 60.17 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -43.54 101.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 26.8 mtpt -87.64 9.19 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.562 1.145 . . . . 0.0 110.466 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 97' ' ' ASN . 79.5 m-20 -122.32 12.63 10.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.332 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 41.33 17.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.215 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 95' ' ' ASP . 51.8 p-10 -84.97 -7.86 58.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.099 0.45 . . . . 0.0 111.296 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.39 24.05 64.06 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.656 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -144.13 179.15 7.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG21 ' CE2' ' A' ' 141' ' ' PHE . 47.0 mm -121.63 121.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.3 t -101.5 166.36 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.732 0.645 . . . . 0.0 110.24 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -74.56 -36.89 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.319 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.89 73.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.576 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 108' ' ' VAL . 93.5 mt-10 -66.23 -32.31 73.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -65.04 -51.37 61.92 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.523 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.17 -44.97 95.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.136 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.589 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 6.9 t60 -68.48 -51.73 40.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 109' ' ' MET . 3.3 p -61.54 -48.48 88.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.799 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.499 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 3.8 mmt -59.45 -45.3 92.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.9 m -64.34 -44.23 92.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.872 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -63.79 -38.04 89.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.09 -35.53 80.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.921 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.74 -9.79 9.12 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.57 105.56 17.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 116' ' ' LEU . 62.0 pttt -57.7 151.73 16.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.989 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -152.12 161.32 42.81 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.354 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -97.42 122.89 40.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.08 -42.73 91.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.78 -34.11 69.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 124' ' ' MET . 95.7 mt-10 -76.14 -40.19 53.27 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -56.55 -61.44 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 109.787 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -52.81 -45.79 67.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -70.23 -36.47 74.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . 19.7 mtt -52.49 -68.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.115 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' CA ' ' A' ' 102' ' ' ALA . 18.3 mt -53.65 -41.19 45.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.275 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -53.97 -39.65 66.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.507 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -79.43 -45.68 18.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.892 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.61 68.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 38.1 t0 -43.12 129.72 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.523 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 mm -91.56 -31.94 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.985 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 58.6 t0 -96.08 -11.1 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 58.33 45.17 94.61 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' GLN . 3.5 p30 -107.03 37.81 2.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.833 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.65 2.9 0.36 Allowed Glycine 0 N--CA 1.46 0.244 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASP . 63.1 mt-30 -149.41 159.7 44.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.309 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.16 151.08 17.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -68.25 -154.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.906 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.98 -53.1 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 141' ' ' PHE . 95.9 mt-10 -56.34 -69.24 0.15 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.668 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' GLU . 96.1 mt-10 -33.03 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.233 0.958 . . . . 0.0 109.727 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.8 t80 -88.48 -56.84 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.459 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 139' ' ' GLU . 46.6 t -33.95 -61.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.214 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -43.11 -66.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -44.17 -51.18 8.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.316 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttm -36.72 114.38 0.3 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -91.23 -41.17 11.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.669 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.43 127.25 21.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.357 -179.698 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 81' ' ' SER . 21.4 p 39.83 75.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.668 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -77.22 16.86 0.53 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 83' ' ' GLU . 78.8 p -123.39 -65.71 1.06 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' N ' ' OG ' ' A' ' 81' ' ' SER . 80.7 tt0 -45.76 -15.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.588 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 18.2 pt-20 -65.24 -52.39 54.85 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.763 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' CG ' ' A' ' 83' ' ' GLU . 82.8 tt0 -47.92 -48.99 31.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.4 mt -53.64 -52.17 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -56.4 -38.57 71.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.711 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.06 -68.48 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.37 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -36.14 -52.66 0.79 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.189 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CE1' ' CD1' ' A' ' 141' ' ' PHE . 28.5 m-85 -66.82 -39.77 87.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.855 0.359 . . . . 0.0 111.354 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -62.8 -48.25 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.733 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.49 -24.3 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.36 -51.51 65.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.113 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 20.8 t0 -52.15 88.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 96' ' ' GLY . 55.3 mtpt -55.39 -58.5 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.241 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 92.9 m-20 -68.82 26.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.595 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 94' ' ' LYS . . . 30.47 35.91 0.01 OUTLIER Glycine 0 CA--C 1.53 0.977 0 O-C-N 123.607 0.567 . . . . 0.0 112.087 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.2 m120 -71.0 -3.88 21.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.049 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 81.13 -4.46 71.29 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 85.4 m-85 -145.33 149.97 35.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.732 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.5 mp -81.33 126.18 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 t -107.54 158.61 17.08 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' CA ' HD12 ' A' ' 125' ' ' ILE . . . -62.93 -39.42 94.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.27 73.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.542 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 93' ' ' ASP . 55.6 mt-10 -70.06 -35.3 74.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' O ' ' SD ' ' A' ' 109' ' ' MET . 83.5 mt -63.42 -53.22 55.72 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.307 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -61.45 -46.73 88.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -63.78 -52.61 59.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.421 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 109' ' ' MET . 2.9 p -62.58 -48.45 88.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.51 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.645 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.5 mtt -56.08 -48.93 75.17 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.9 m -63.36 -44.58 94.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 109.997 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.06 -40.29 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.901 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.29 -37.8 84.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.298 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.58 -4.63 4.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.95 102.07 10.85 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 110.614 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.63 93.07 9.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' SD ' ' A' ' 109' ' ' MET . 8.3 mt -78.07 -167.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.26 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.1 p -102.42 122.41 44.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.775 0.322 . . . . 0.0 110.167 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.45 -36.91 46.13 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.75 -33.24 74.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 124' ' ' MET . 83.6 tt0 -74.6 -49.4 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 124' ' ' MET . 14.3 t -49.25 -69.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-O 121.895 0.855 . . . . 0.0 109.271 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -43.83 -43.67 6.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -67.66 -37.74 82.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.359 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 55.4 mmm -52.0 -70.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 136' ' ' VAL . 34.1 mt -52.38 -44.18 42.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.887 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -51.18 -41.32 60.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.21 -39.31 25.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -65.67 -56.43 12.16 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.962 0.41 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.2 t0 -45.84 133.63 8.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.239 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -92.49 -23.34 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.855 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 26.1 m-20 -111.83 -3.54 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 54.41 53.47 38.1 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 135' ' ' GLN . 35.5 p30 -114.43 33.47 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.167 . . . . 0.0 110.821 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 47.85 6.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 133' ' ' ASP . 15.6 mm100 -126.14 112.71 16.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 125' ' ' ILE . 77.4 t -112.21 133.21 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 110.198 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -72.54 -151.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.0 m-85 -87.8 -57.86 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.567 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 141' ' ' PHE . 68.3 mm-40 -58.84 -68.71 0.24 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.036 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 139' ' ' GLU . 87.6 mt-10 -29.85 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.356 1.035 . . . . 0.0 109.221 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.627 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.6 t80 -83.81 -54.93 4.54 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.568 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' GLU . 78.5 t -39.17 -65.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -44.05 -13.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.572 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.72 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -100.96 -51.83 3.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.044 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.3 ttp -64.19 151.62 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.622 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.6 p -113.7 -12.15 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.236 0.335 . . . . 0.0 110.627 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.42 147.43 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 tttp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.614 179.729 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_